https://www.bellevue.ch/all-de/all2025-06-25T14:00:50+02:00https://www.bellevue.ch/all-de/all/produkte2024-12-09T13:53:48+01:00https://www.bellevue.ch/all-de/all/produkte/healthcare-investments2021-12-17T11:44:36+01:00https://www.bellevue.ch/all-de/all/produkte/healthcare-investments/biotech/bb-biotech-ag/bb-biotech-ag-six-chf2024-07-16T20:53:00+02:00https://www.bellevue.ch/all-de/all/produkte/healthcare-investments/biotech/bb-biotech-ag/bb-biotech-ag-xetra-eur2024-07-16T20:53:00+02:00https://www.bellevue.ch/all-de/all/produkte/healthcare-investments/biotech/bellevue-biotech-ch/aa-anteile-chf2024-07-16T20:55:55+02:00https://www.bellevue.ch/all-de/all/produkte/healthcare-investments/biotech/bellevue-biotech-ch/dt-anteile-chf2024-07-16T20:55:55+02:00https://www.bellevue.ch/all-de/all/produkte/healthcare-investments/medtech/bellevue-medtech-services/i-anteile-eur2024-07-16T21:03:06+02:00https://www.bellevue.ch/all-de/all/produkte/healthcare-investments/medtech/bellevue-medtech-services/ai-anteile-eur2024-07-16T21:03:06+02:00https://www.bellevue.ch/all-de/all/produkte/healthcare-investments/medtech/bellevue-medtech-services/hi-anteile-eur2024-07-16T21:03:06+02:00https://www.bellevue.ch/all-de/all/produkte/healthcare-investments/medtech/bellevue-medtech-services/i-anteile-usd2024-07-16T21:03:06+02:00https://www.bellevue.ch/all-de/all/produkte/healthcare-investments/medtech/bellevue-medtech-services/i-anteile-gbp2025-06-24T14:29:49+02:00https://www.bellevue.ch/all-de/all/produkte/healthcare-investments/medtech/bellevue-medtech-services/i2-anteile-usd2024-07-16T21:03:06+02:00https://www.bellevue.ch/all-de/all/produkte/healthcare-investments/medtech/bellevue-medtech-services/i2-anteile-eur2025-06-24T14:37:08+02:00https://www.bellevue.ch/all-de/all/produkte/healthcare-investments/medtech/bellevue-medtech-services/u-anteile-eur2024-07-16T21:03:06+02:00https://www.bellevue.ch/all-de/all/produkte/healthcare-investments/medtech/bellevue-medtech-services/u-anteile-chf2024-07-16T21:03:06+02:00https://www.bellevue.ch/all-de/all/produkte/healthcare-investments/medtech/bellevue-medtech-services/u-anteile-usd2024-07-16T21:03:06+02:00https://www.bellevue.ch/all-de/all/produkte/healthcare-investments/medtech/bellevue-medtech-services/u2-anteile-eur2024-07-16T21:03:06+02:00https://www.bellevue.ch/all-de/all/produkte/healthcare-investments/medtech/bellevue-medtech-services/u2-anteile-usd2024-07-16T21:03:06+02:00https://www.bellevue.ch/all-de/all/produkte/healthcare-investments/medtech/bellevue-medtech-services/b-anteile-eur2024-07-16T21:03:06+02:00https://www.bellevue.ch/all-de/all/produkte/healthcare-investments/medtech/bellevue-medtech-services/hb-anteile-eur2025-03-03T10:05:15+01:00https://www.bellevue.ch/all-de/all/produkte/healthcare-investments/medtech/bellevue-medtech-services/hb-anteile-chf2024-07-16T21:03:06+02:00https://www.bellevue.ch/all-de/all/produkte/healthcare-investments/medtech/bellevue-medtech-services/b-anteile-usd2025-03-01T00:51:57+01:00https://www.bellevue.ch/all-de/all/produkte/healthcare-investments/medtech/bellevue-medtech-services/t-anteile-chf2025-03-01T00:52:10+01:00https://www.bellevue.ch/all-de/all/produkte/healthcare-investments/medtech/bellevue-medtech-services/t-anteile-eur2025-03-01T00:52:19+01:00https://www.bellevue.ch/all-de/all/produkte/healthcare-investments/medtech/bellevue-medtech-services/u2-anteile-chf2025-07-24T00:49:26+02:00https://www.bellevue.ch/all-de/all/produkte/healthcare-investments/medtech/bellevue-medtech-services/i-anteile-chf2025-07-24T00:49:43+02:00https://www.bellevue.ch/all-de/all/produkte/healthcare-investments/medtech/bellevue-medtech-services/b-anteile-chf2025-07-24T00:49:48+02:00https://www.bellevue.ch/all-de/all/produkte/healthcare-investments/medtech/bellevue-medtech-services-ch/aa-anteile-chf2024-07-16T21:12:30+02:00https://www.bellevue.ch/all-de/all/produkte/healthcare-investments/medtech/bellevue-medtech-services-ch/dt-anteile-chf2024-07-16T21:12:30+02:00https://www.bellevue.ch/all-de/all/produkte/healthcare-investments/thematic/bellevue-ai-health/i-anteile-usd2024-07-16T21:12:30+02:00https://www.bellevue.ch/all-de/all/produkte/healthcare-investments/thematic/bellevue-ai-health/i-anteile-chf2024-07-16T21:12:30+02:00https://www.bellevue.ch/all-de/all/produkte/healthcare-investments/thematic/bellevue-ai-health/i-anteile-eur2024-07-16T21:12:30+02:00https://www.bellevue.ch/all-de/all/produkte/healthcare-investments/thematic/bellevue-ai-health/i2-anteile-usd2024-07-16T21:12:30+02:00https://www.bellevue.ch/all-de/all/produkte/healthcare-investments/thematic/bellevue-ai-health/i2-anteile-eur2024-07-16T21:12:30+02:00https://www.bellevue.ch/all-de/all/produkte/healthcare-investments/thematic/bellevue-ai-health/u2-anteile-chf2024-07-16T21:12:30+02:00https://www.bellevue.ch/all-de/all/produkte/healthcare-investments/thematic/bellevue-ai-health/b-anteile-chf2024-07-16T21:12:30+02:00https://www.bellevue.ch/all-de/all/produkte/healthcare-investments/thematic/bellevue-ai-health/b-anteile-eur2024-07-16T21:12:30+02:00https://www.bellevue.ch/all-de/all/produkte/healthcare-investments/thematic/bellevue-ai-health/u2-anteile-eur2025-02-12T00:48:48+01:00https://www.bellevue.ch/all-de/all/produkte/healthcare-investments/thematic/bellevue-ai-health/i2-anteile-chf2025-02-12T00:49:00+01:00https://www.bellevue.ch/all-de/all/produkte/healthcare-investments/thematic/bellevue-ai-health/b-anteile-usd2025-02-12T00:49:05+01:00https://www.bellevue.ch/all-de/all/produkte/healthcare-investments/thematic/bellevue-ai-health/u2-anteile-usd2025-02-12T00:49:10+01:00https://www.bellevue.ch/all-de/all/produkte/healthcare-investments/thematic/bellevue-digital-health/i-anteile-usd2024-07-16T21:26:52+02:00https://www.bellevue.ch/all-de/all/produkte/healthcare-investments/thematic/bellevue-digital-health/ai2-anteile-usd2024-07-16T21:26:52+02:00https://www.bellevue.ch/all-de/all/produkte/healthcare-investments/thematic/bellevue-digital-health/u2-anteile-usd2024-07-16T21:26:52+02:00https://www.bellevue.ch/all-de/all/produkte/healthcare-investments/thematic/bellevue-digital-health/b-anteile-usd2024-07-16T21:26:52+02:00https://www.bellevue.ch/all-de/all/produkte/healthcare-investments/thematic/bellevue-digital-health/i2-anteile-chf2025-12-22T07:50:39+01:00https://www.bellevue.ch/all-de/all/produkte/healthcare-investments/thematic/bellevue-digital-health/i2-anteile-eur2025-12-22T07:50:46+01:00https://www.bellevue.ch/all-de/all/produkte/healthcare-investments/thematic/bellevue-digital-health/hb-anteile-eur2026-03-18T04:21:02+01:00https://www.bellevue.ch/all-de/all/produkte/healthcare-investments/thematic/bellevue-digital-health/b-anteile-chf2025-12-22T07:50:53+01:00https://www.bellevue.ch/all-de/all/produkte/healthcare-investments/thematic/bellevue-digital-health/i-anteile-eur2025-12-22T07:50:56+01:00https://www.bellevue.ch/all-de/all/produkte/healthcare-investments/thematic/bellevue-digital-health/i-anteile-chf2025-12-22T07:50:59+01:00https://www.bellevue.ch/all-de/all/produkte/healthcare-investments/thematic/bellevue-digital-health/i2-anteile-usd2025-12-22T07:51:03+01:00https://www.bellevue.ch/all-de/all/produkte/healthcare-investments/thematic/bellevue-digital-health/b-anteile-eur2025-12-22T07:51:07+01:00https://www.bellevue.ch/all-de/all/produkte/healthcare-investments/thematic/bellevue-digital-health/eur2025-12-22T07:51:10+01:00https://www.bellevue.ch/all-de/all/produkte/healthcare-investments/thematic/bellevue-obesity-solutions/i-anteile-usd2024-10-07T16:48:39+02:00https://www.bellevue.ch/all-de/all/produkte/healthcare-investments/thematic/bellevue-obesity-solutions/i-anteile-chf2024-07-16T21:26:52+02:00https://www.bellevue.ch/all-de/all/produkte/healthcare-investments/thematic/bellevue-obesity-solutions/i-anteile-eur2024-07-16T21:26:52+02:00https://www.bellevue.ch/all-de/all/produkte/healthcare-investments/thematic/bellevue-obesity-solutions/i-anteile-gbp2024-07-16T21:26:52+02:00https://www.bellevue.ch/all-de/all/produkte/healthcare-investments/thematic/bellevue-obesity-solutions/i2-anteile-usd2024-07-16T21:26:52+02:00https://www.bellevue.ch/all-de/all/produkte/healthcare-investments/thematic/bellevue-obesity-solutions/i2-anteile-chf2024-07-16T21:26:52+02:00https://www.bellevue.ch/all-de/all/produkte/healthcare-investments/thematic/bellevue-obesity-solutions/i2-anteile-eur2024-10-15T13:24:36+02:00https://www.bellevue.ch/all-de/all/produkte/healthcare-investments/thematic/bellevue-obesity-solutions/b-anteile-usd2024-07-16T21:26:52+02:00https://www.bellevue.ch/all-de/all/produkte/healthcare-investments/thematic/bellevue-obesity-solutions/b-anteile-chf2024-07-16T21:26:52+02:00https://www.bellevue.ch/all-de/all/produkte/healthcare-investments/thematic/bellevue-obesity-solutions/b-anteile-eur2024-07-16T21:26:52+02:00https://www.bellevue.ch/all-de/all/produkte/healthcare-investments/healthcare-global/bellevue-diversified-healthcare/i-anteile-chf2024-07-16T21:40:20+02:00https://www.bellevue.ch/all-de/all/produkte/healthcare-investments/healthcare-global/bellevue-diversified-healthcare/i-anteile-eur2024-07-16T21:40:20+02:00https://www.bellevue.ch/all-de/all/produkte/healthcare-investments/healthcare-global/bellevue-diversified-healthcare/i2-anteile-usd2024-07-16T21:40:20+02:00https://www.bellevue.ch/all-de/all/produkte/healthcare-investments/healthcare-global/bellevue-diversified-healthcare/i2-anteile-chf2024-07-16T21:40:20+02:00https://www.bellevue.ch/all-de/all/produkte/healthcare-investments/healthcare-global/bellevue-diversified-healthcare/i2-anteile-eur2024-07-16T21:40:20+02:00https://www.bellevue.ch/all-de/all/produkte/healthcare-investments/healthcare-global/bellevue-diversified-healthcare/u-anteile-chf2024-07-16T21:40:20+02:00https://www.bellevue.ch/all-de/all/produkte/healthcare-investments/healthcare-global/bellevue-diversified-healthcare/u-anteile-eur2024-07-16T21:40:20+02:00https://www.bellevue.ch/all-de/all/produkte/healthcare-investments/healthcare-global/bellevue-diversified-healthcare/u2-anteile-chf2024-07-16T21:40:20+02:00https://www.bellevue.ch/all-de/all/produkte/healthcare-investments/healthcare-global/bellevue-diversified-healthcare/u2-anteile-eur2024-07-16T21:40:20+02:00https://www.bellevue.ch/all-de/all/produkte/healthcare-investments/healthcare-global/bellevue-diversified-healthcare/b-anteile-usd2024-07-16T21:40:20+02:00https://www.bellevue.ch/all-de/all/produkte/healthcare-investments/healthcare-global/bellevue-diversified-healthcare/b-anteile-chf2024-07-16T21:40:20+02:00https://www.bellevue.ch/all-de/all/produkte/healthcare-investments/healthcare-global/bellevue-diversified-healthcare/u-anteile-usd2024-12-28T00:30:21+01:00https://www.bellevue.ch/all-de/all/produkte/healthcare-investments/healthcare-global/bellevue-diversified-healthcare/b-anteile-eur2025-08-29T00:31:50+02:00https://www.bellevue.ch/all-de/all/produkte/healthcare-investments/healthcare-global/bellevue-diversified-healthcare/u2-anteile-usd2025-08-29T00:32:03+02:00https://www.bellevue.ch/all-de/all/produkte/healthcare-investments/healthcare-global/bellevue-diversified-healthcare/i-anteile-usd2025-08-29T00:32:09+02:00https://www.bellevue.ch/all-de/all/produkte/healthcare-investments/healthcare-global/bellevue-healthcare-etf/care-usd2025-09-25T01:25:45+02:00https://www.bellevue.ch/all-de/all/produkte/healthcare-investments/healthcare-global/bellevue-healthcare-strategy/i-anteile-usd2024-07-16T21:54:46+02:00https://www.bellevue.ch/all-de/all/produkte/healthcare-investments/healthcare-global/bellevue-healthcare-strategy/i-anteile-chf2024-07-16T21:54:46+02:00https://www.bellevue.ch/all-de/all/produkte/healthcare-investments/healthcare-global/bellevue-healthcare-strategy/i-anteile-eur2024-07-16T21:54:46+02:00https://www.bellevue.ch/all-de/all/produkte/healthcare-investments/healthcare-global/bellevue-healthcare-strategy/i2-anteile-usd2024-07-16T21:54:46+02:00https://www.bellevue.ch/all-de/all/produkte/healthcare-investments/healthcare-global/bellevue-healthcare-strategy/i2-anteile-chf2024-07-16T21:54:46+02:00https://www.bellevue.ch/all-de/all/produkte/healthcare-investments/healthcare-global/bellevue-healthcare-strategy/i2-anteile-eur2024-07-16T21:54:46+02:00https://www.bellevue.ch/all-de/all/produkte/healthcare-investments/healthcare-global/bellevue-healthcare-strategy/usd2024-07-24T00:40:25+02:00https://www.bellevue.ch/all-de/all/produkte/healthcare-investments/healthcare-global/bellevue-healthcare-strategy/eur2024-07-24T00:40:17+02:00https://www.bellevue.ch/all-de/all/produkte/healthcare-investments/healthcare-global/bellevue-healthcare-strategy/b-anteile-chf2024-07-16T21:54:46+02:00https://www.bellevue.ch/all-de/all/produkte/healthcare-investments/healthcare-global/bellevue-healthcare-strategy/b-anteile-eur2024-07-16T21:54:46+02:00https://www.bellevue.ch/all-de/all/produkte/healthcare-investments/healthcare-global/bellevue-healthcare-strategy/b-anteile-usd2026-02-03T00:45:56+01:00https://www.bellevue.ch/all-de/all/produkte/healthcare-investments/healthcare-global/bellevue-healthcare-strategy-ch/i-anteile-chf2024-07-16T21:54:46+02:00https://www.bellevue.ch/all-de/all/produkte/healthcare-investments/healthcare-global/bellevue-healthcare-strategy-ch/ia-anteile-chf2024-07-16T21:54:46+02:00https://www.bellevue.ch/all-de/all/produkte/healthcare-investments/healthcare-global/bellevue-healthcare-strategy-ch/ia-anteile-usd2024-07-16T21:54:46+02:00https://www.bellevue.ch/all-de/all/produkte/healthcare-investments/healthcare-global/bellevue-healthcare-strategy-ch/i2-anteile-chf2024-07-16T21:54:46+02:00https://www.bellevue.ch/all-de/all/produkte/healthcare-investments/healthcare-global/bellevue-healthcare-strategy-ch/i2-anteile-usd2024-07-16T21:54:46+02:00https://www.bellevue.ch/all-de/all/produkte/healthcare-investments/healthcare-global/bellevue-healthcare-strategy-ch/t-anteile-chf2024-07-16T21:54:46+02:00https://www.bellevue.ch/all-de/all/produkte/healthcare-investments/healthcare-global/bellevue-healthcare-strategy-ch/t-anteile-usd2024-07-16T21:54:46+02:00https://www.bellevue.ch/all-de/all/produkte/healthcare-investments/healthcare-global/bellevue-healthcare-strategy-ch/i2-anteile-eur2024-07-24T00:46:36+02:00https://www.bellevue.ch/all-de/all/produkte/healthcare-investments/healthcare-global/bellevue-healthcare-strategy-ch/i-anteile-usd2025-02-13T11:00:18+01:00https://www.bellevue.ch/all-de/all/produkte/healthcare-investments/healthcare-global/bellevue-sustainable-healthcare/i-anteile-usd2024-07-18T07:02:03+02:00https://www.bellevue.ch/all-de/all/produkte/healthcare-investments/healthcare-global/bellevue-sustainable-healthcare/i-anteile-chf2024-07-18T07:02:03+02:00https://www.bellevue.ch/all-de/all/produkte/healthcare-investments/healthcare-global/bellevue-sustainable-healthcare/i-anteile-eur2024-07-18T07:02:03+02:00https://www.bellevue.ch/all-de/all/produkte/healthcare-investments/healthcare-global/bellevue-sustainable-healthcare/i2-anteile-usd2024-07-18T07:02:03+02:00https://www.bellevue.ch/all-de/all/produkte/healthcare-investments/healthcare-global/bellevue-sustainable-healthcare/i2-anteile-chf2024-07-18T07:02:03+02:00https://www.bellevue.ch/all-de/all/produkte/healthcare-investments/healthcare-global/bellevue-sustainable-healthcare/i2-anteile-eur2024-07-18T07:02:03+02:00https://www.bellevue.ch/all-de/all/produkte/healthcare-investments/healthcare-global/bellevue-sustainable-healthcare/ai2-anteile-eur2024-07-18T07:02:03+02:00https://www.bellevue.ch/all-de/all/produkte/healthcare-investments/healthcare-global/bellevue-sustainable-healthcare/u2-anteile-eur2024-07-18T07:02:03+02:00https://www.bellevue.ch/all-de/all/produkte/healthcare-investments/healthcare-global/bellevue-sustainable-healthcare/s2-anteile-chf2025-12-15T10:08:06+01:00https://www.bellevue.ch/all-de/all/produkte/healthcare-investments/healthcare-global/bellevue-sustainable-healthcare/b-anteile-usd2024-07-18T07:02:03+02:00https://www.bellevue.ch/all-de/all/produkte/healthcare-investments/healthcare-global/bellevue-sustainable-healthcare/b-anteile-chf2024-07-18T07:02:03+02:00https://www.bellevue.ch/all-de/all/produkte/healthcare-investments/healthcare-global/bellevue-sustainable-healthcare/b-anteile-eur2024-07-18T07:02:03+02:00https://www.bellevue.ch/all-de/all/produkte/healthcare-investments/healthcare-regional/bellevue-asia-pacific-healthcare/i-anteile-usd2024-07-16T22:10:43+02:00https://www.bellevue.ch/all-de/all/produkte/healthcare-investments/healthcare-regional/bellevue-asia-pacific-healthcare/i-anteile-chf2024-07-16T22:10:43+02:00https://www.bellevue.ch/all-de/all/produkte/healthcare-investments/healthcare-regional/bellevue-asia-pacific-healthcare/i-anteile-eur2024-07-16T22:10:43+02:00https://www.bellevue.ch/all-de/all/produkte/healthcare-investments/healthcare-regional/bellevue-asia-pacific-healthcare/ai2-anteile-usd2024-07-16T22:10:43+02:00https://www.bellevue.ch/all-de/all/produkte/healthcare-investments/healthcare-regional/bellevue-asia-pacific-healthcare/i2-anteile-chf2024-07-16T22:10:43+02:00https://www.bellevue.ch/all-de/all/produkte/healthcare-investments/healthcare-regional/bellevue-asia-pacific-healthcare/b-anteile-usd2024-07-16T22:10:43+02:00https://www.bellevue.ch/all-de/all/produkte/healthcare-investments/healthcare-regional/bellevue-asia-pacific-healthcare/i2-anteile-usd2024-10-22T00:48:34+02:00https://www.bellevue.ch/all-de/all/produkte/healthcare-investments/healthcare-regional/bellevue-asia-pacific-healthcare/b-anteile-chf2024-10-22T00:48:46+02:00https://www.bellevue.ch/all-de/all/produkte/healthcare-investments/healthcare-regional/bellevue-asia-pacific-healthcare/b-anteile-eur2025-09-10T00:45:08+02:00https://www.bellevue.ch/all-de/all/produkte/healthcare-investments/healthcare-regional/bellevue-asia-pacific-healthcare/i2-anteile-eur2026-03-24T01:17:33+01:00https://www.bellevue.ch/all-de/all/produkte/healthcare-investments/healthcare-regional/bellevue-emerging-markets-healthcare/i-anteile-chf2024-07-16T22:21:40+02:00https://www.bellevue.ch/all-de/all/produkte/healthcare-investments/healthcare-regional/bellevue-emerging-markets-healthcare/i2-anteile-chf2024-07-16T22:21:40+02:00https://www.bellevue.ch/all-de/all/produkte/healthcare-investments/healthcare-regional/bellevue-emerging-markets-healthcare/i2-anteile-eur2025-07-02T00:42:10+02:00https://www.bellevue.ch/all-de/all/produkte/healthcare-investments/healthcare-regional/bellevue-emerging-markets-healthcare/b-anteile-chf2025-07-02T00:42:15+02:00https://www.bellevue.ch/all-de/all/produkte/healthcare-investments/healthcare-regional/bellevue-emerging-markets-healthcare/b-anteile-eur2025-07-02T00:42:20+02:00https://www.bellevue.ch/all-de/all/produkte/healthcare-investments/healthcare-regional/bellevue-emerging-markets-healthcare/i2-anteile-usd2025-07-02T00:42:32+02:00https://www.bellevue.ch/all-de/all/produkte/healthcare-investments/healthcare-regional/bellevue-emerging-markets-healthcare/i-anteile-eur2025-07-02T00:42:37+02:00https://www.bellevue.ch/all-de/all/produkte/healthcare-investments/healthcare-regional/bellevue-emerging-markets-healthcare/b-anteile-usd2025-09-09T00:55:07+02:00https://www.bellevue.ch/all-de/all/produkte/healthcare-investments/healthcare-regional/bellevue-emerging-markets-healthcare/i-anteile-usd2025-09-09T00:55:23+02:00https://www.bellevue.ch/all-de/all/produkte/small-mid-sized-entrepreneur-investments2025-11-03T09:46:48+01:00https://www.bellevue.ch/all-de/all/produkte/small-mid-sized-entrepreneur-investments/listed-small-mid-caps/bellevue-entrepreneur-europe-small/i-anteile-eur2025-10-29T13:55:40+01:00https://www.bellevue.ch/all-de/all/produkte/small-mid-sized-entrepreneur-investments/listed-small-mid-caps/bellevue-entrepreneur-europe-small/hi-anteile-chf2024-07-16T22:31:56+02:00https://www.bellevue.ch/all-de/all/produkte/small-mid-sized-entrepreneur-investments/listed-small-mid-caps/bellevue-entrepreneur-europe-small/i2-anteile-eur2024-07-16T22:31:56+02:00https://www.bellevue.ch/all-de/all/produkte/small-mid-sized-entrepreneur-investments/listed-small-mid-caps/bellevue-entrepreneur-europe-small/b-anteile-eur2024-07-16T22:31:56+02:00https://www.bellevue.ch/all-de/all/produkte/small-mid-sized-entrepreneur-investments/listed-small-mid-caps/bellevue-entrepreneur-europe-small/b-anteile-chf2024-07-16T22:31:56+02:00https://www.bellevue.ch/all-de/all/produkte/small-mid-sized-entrepreneur-investments/listed-small-mid-caps/bellevue-entrepreneur-europe-small/ai-anteile-eur2024-07-25T01:07:51+02:00https://www.bellevue.ch/all-de/all/produkte/small-mid-sized-entrepreneur-investments/listed-small-mid-caps/bellevue-entrepreneur-europe-small/i-anteile-chf2025-05-01T02:26:45+02:00https://www.bellevue.ch/all-de/all/produkte/small-mid-sized-entrepreneur-investments/listed-small-mid-caps/bellevue-entrepreneur-europe-small/ab-anteile-eur2025-05-01T02:26:58+02:00https://www.bellevue.ch/all-de/all/produkte/small-mid-sized-entrepreneur-investments/listed-small-mid-caps/bellevue-entrepreneur-swiss-small-mid/i2-anteile-chf2025-05-04T01:37:41+02:00https://www.bellevue.ch/all-de/all/produkte/small-mid-sized-entrepreneur-investments/listed-small-mid-caps/bellevue-entrepreneur-swiss-small-mid/i-anteile-chf2025-06-28T00:53:04+02:00https://www.bellevue.ch/all-de/all/produkte/small-mid-sized-entrepreneur-investments/listed-small-mid-caps/bellevue-entrepreneur-swiss-small-mid/i-anteile-eur2025-06-28T00:53:12+02:00https://www.bellevue.ch/all-de/all/produkte/small-mid-sized-entrepreneur-investments/listed-small-mid-caps/bellevue-entrepreneur-swiss-small-mid/b-anteile-chf2025-06-28T00:53:17+02:00https://www.bellevue.ch/all-de/all/produkte/small-mid-sized-entrepreneur-investments/listed-small-mid-caps/bellevue-entrepreneur-swiss-small-mid/b-anteile-eur2025-12-27T02:41:14+01:00https://www.bellevue.ch/all-de/all/produkte/small-mid-sized-entrepreneur-investments/listed-small-mid-caps/bellevue-entrepreneur-switzerland-ch/i-anteile-chf2024-07-16T22:42:11+02:00https://www.bellevue.ch/all-de/all/produkte/small-mid-sized-entrepreneur-investments/listed-small-mid-caps/bellevue-entrepreneur-switzerland-ch/a-anteile-chf2024-07-16T22:42:11+02:00https://www.bellevue.ch/all-de/all/produkte/small-mid-sized-entrepreneur-investments/listed-small-mid-caps/bellevue-entrepreneur-switzerland-ch/b-anteile-chf2024-07-16T22:42:11+02:00https://www.bellevue.ch/all-de/all/produkte/small-mid-sized-entrepreneur-investments/private-equity-strategies/bellevue-entrepreneur-private/bellevue-entrepreneur-private-chf2024-08-06T01:01:24+02:00https://www.bellevue.ch/all-de/all/produkte/multi-asset-bonds-alternatives2025-11-03T09:47:51+01:00https://www.bellevue.ch/all-de/all/produkte/multi-asset-bonds-alternatives/multi-asset/bellevue-global-macro/i-anteile-eur2025-06-26T10:19:36+02:00https://www.bellevue.ch/all-de/all/produkte/multi-asset-bonds-alternatives/multi-asset/bellevue-global-macro/ai-anteile-eur2025-06-26T10:19:36+02:00https://www.bellevue.ch/all-de/all/produkte/multi-asset-bonds-alternatives/multi-asset/bellevue-global-macro/hi-anteile-chf2025-06-26T10:19:36+02:00https://www.bellevue.ch/all-de/all/produkte/multi-asset-bonds-alternatives/multi-asset/bellevue-global-macro/hi-anteile-usd2025-06-26T10:19:36+02:00https://www.bellevue.ch/all-de/all/produkte/multi-asset-bonds-alternatives/multi-asset/bellevue-global-macro/hi-anteile-gbp2025-06-26T10:19:36+02:00https://www.bellevue.ch/all-de/all/produkte/multi-asset-bonds-alternatives/multi-asset/bellevue-global-macro/i2-anteile-eur2025-06-26T10:19:36+02:00https://www.bellevue.ch/all-de/all/produkte/multi-asset-bonds-alternatives/multi-asset/bellevue-global-macro/i2-anteile-usd2025-06-26T10:19:36+02:00https://www.bellevue.ch/all-de/all/produkte/multi-asset-bonds-alternatives/multi-asset/bellevue-global-macro/hi2-anteile-chf2025-06-26T10:19:36+02:00https://www.bellevue.ch/all-de/all/produkte/multi-asset-bonds-alternatives/multi-asset/bellevue-global-macro/b-anteile-eur2025-06-26T10:19:36+02:00https://www.bellevue.ch/all-de/all/produkte/multi-asset-bonds-alternatives/multi-asset/bellevue-global-macro/ab-anteile-eur2025-06-26T10:19:36+02:00https://www.bellevue.ch/all-de/all/produkte/multi-asset-bonds-alternatives/multi-asset/bellevue-global-macro/hb-anteile-chf2025-06-26T10:19:36+02:00https://www.bellevue.ch/all-de/all/produkte/multi-asset-bonds-alternatives/multi-asset/bellevue-global-macro/hb-anteile-usd2025-06-26T10:19:36+02:00https://www.bellevue.ch/all-de/all/produkte/multi-asset-bonds-alternatives/bonds/bellevue-global-income/i-anteile-eur2024-07-16T23:06:12+02:00https://www.bellevue.ch/all-de/all/produkte/multi-asset-bonds-alternatives/bonds/bellevue-global-income/hi-anteile-chf2024-07-16T23:06:12+02:00https://www.bellevue.ch/all-de/all/produkte/multi-asset-bonds-alternatives/bonds/bellevue-global-income/hi-anteile-usd2024-07-16T23:06:12+02:00https://www.bellevue.ch/all-de/all/produkte/multi-asset-bonds-alternatives/bonds/bellevue-global-income/i2-anteile-eur2025-08-15T13:40:03+02:00https://www.bellevue.ch/all-de/all/produkte/multi-asset-bonds-alternatives/bonds/bellevue-global-income/hi2-anteile-usd2025-08-15T13:36:59+02:00https://www.bellevue.ch/all-de/all/produkte/multi-asset-bonds-alternatives/bonds/bellevue-global-income/hi2-anteile-chf2024-07-16T23:06:12+02:00https://www.bellevue.ch/all-de/all/produkte/multi-asset-bonds-alternatives/bonds/bellevue-global-income/hu2-anteile-chf2024-07-16T23:06:12+02:00https://www.bellevue.ch/all-de/all/produkte/multi-asset-bonds-alternatives/bonds/bellevue-global-income/hb-anteile-chf2024-07-16T23:06:12+02:00https://www.bellevue.ch/all-de/all/produkte/multi-asset-bonds-alternatives/bonds/bellevue-global-income/hb-anteile-usd2024-07-16T23:06:12+02:00https://www.bellevue.ch/all-de/all/produkte/multi-asset-bonds-alternatives/bonds/bellevue-global-income/b-anteile-eur2025-03-02T01:06:06+01:00https://www.bellevue.ch/all-de/all/produkte/multi-asset-bonds-alternatives/bonds/bellevue-global-income/ai-anteile-eur2025-12-12T04:05:26+01:00https://www.bellevue.ch/all-de/all/produkte/multi-asset-bonds-alternatives/bonds/bellevue-global-income/ab-anteile-eur2025-12-12T04:05:40+01:00https://www.bellevue.ch/all-de/all/produkte/produktuebersicht2025-10-20T18:07:50+02:00https://www.bellevue.ch/all-de/all/insights2024-12-12T10:23:53+01:00https://www.bellevue.ch/all-de/all/insights/newsletter2021-11-01T13:46:20+01:00https://www.bellevue.ch/all-de/all/insights/gesunde-digitalisierung2022-09-12T16:39:43+02:00https://www.bellevue.ch/all-de/all/insights/demografie-und-innovation-sorgen-fuer-sehr-hohes-gewinnwachstum2022-09-12T16:41:31+02:00https://www.bellevue.ch/all-de/all/insights/der-gesamte-biotechsektor-wie-auch-bb-biotech-fanden-im-jahr-2021-ein-volatiles-marktumfeld-vor2022-01-24T09:34:25+01:00https://www.bellevue.ch/all-de/all/insights/benjamin-boehner-es-geht-auch-ohne-financial-leverage2022-05-25T15:22:17+02:00https://www.bellevue.ch/all-de/all/insights/vier-gruende-fuer-biotech-aktien2021-09-13T13:20:47+02:00https://www.bellevue.ch/all-de/all/insights/bellevue-baut-sales-aktivitaeten-im-asiatischen-raum-weiter-aus2021-09-13T13:20:47+02:00https://www.bellevue.ch/all-de/all/insights/zulassung-von-alzheimermedikament-erregt-aufsehen2022-09-12T16:51:05+02:00https://www.bellevue.ch/all-de/all/insights/bellevue-insight-christian-lach-lukas-leu2021-09-13T13:20:47+02:00https://www.bellevue.ch/all-de/all/insights/birgitte-olsen-im-bellevue-portfolio-manager-spotlight2022-05-25T15:25:45+02:00https://www.bellevue.ch/all-de/all/insights/die-gewinne-steigen-staerker-als-die-kurse-aktien-werden-guenstiger2022-09-12T16:48:43+02:00https://www.bellevue.ch/all-de/all/insights/bb-biotech-wir-erwarten-einen-gewaltigen-schub-der-mit-mrna-therapien-gesammelten-erfahrungen2022-09-12T16:52:50+02:00https://www.bellevue.ch/all-de/all/insights/blog-paul-and-bretts-alpha2021-11-08T10:03:48+01:00https://www.bellevue.ch/all-de/all/insights/nachhaltigkeit-und-gesundheit-vereint-im-portfolio-eine-gelungene-kombination2021-09-09T20:03:22+02:00https://www.bellevue.ch/all-de/all/insights/bb-biotech-erhoeht-allokation-in-aussichtsreiche-small-und-mid-caps2022-09-12T16:55:02+02:00https://www.bellevue.ch/all-de/all/insights/q2-update-mit-dr-daniel-koller2021-09-09T20:03:22+02:00https://www.bellevue.ch/all-de/all/insights/nachhaltig-verwaltete-healthcare-investments-treffen-den-nerv-der-zeit2021-09-09T20:03:22+02:00https://www.bellevue.ch/all-de/all/insights/second-insights-article2021-09-10T10:51:48+02:00https://www.bellevue.ch/all-de/all/insights/abseits-der-boerse-bietet-die-schweiz-eine-vielzahl-von-innovativen-firmen-sogenannte-hidden-champions2022-09-12T17:01:42+02:00https://www.bellevue.ch/all-de/all/insights/mrna-technologie-durchbruch-mit-grosser-zukunft2021-09-09T20:03:22+02:00https://www.bellevue.ch/all-de/all/insights/dieser-innovationsschub-befluegelt-die-branche2021-09-09T20:03:22+02:00https://www.bellevue.ch/all-de/all/insights/das-hohe-esg-engagement-der-familienunternehmen2024-07-29T15:49:31+02:00https://www.bellevue.ch/all-de/all/insights/hoffnung-fuer-alzheimerpatienten2024-12-12T09:23:50+01:00https://www.bellevue.ch/all-de/all/insights/in-geschichten-statt-in-laender-diversifizieren2024-07-29T16:17:40+02:00https://www.bellevue.ch/all-de/all/insights/sustainable-healthcare-performance-review-outlook2021-09-09T20:03:22+02:00https://www.bellevue.ch/all-de/all/insights/bellevue-gibt-erstes-erfolgreiches-closing-fuer-die-bb-entrepreneur-privatestrategie-bekannt2021-09-09T20:03:22+02:00https://www.bellevue.ch/all-de/all/insights/weltweite-corona-impfstofferfolge-lassen-den-sektor-erstrahlen2021-09-09T20:03:22+02:00https://www.bellevue.ch/all-de/all/insights/gesunde-innovationen2021-09-09T20:03:22+02:00https://www.bellevue.ch/all-de/all/insights/triumph-einer-neuen-medikamentenklasse2024-12-12T09:33:34+01:00https://www.bellevue.ch/all-de/all/insights/digitalisierung-erreicht-gesundheitssektor-und-verzeichnet-rekordwachstum2021-09-09T20:03:22+02:00https://www.bellevue.ch/all-de/all/insights/healthcare-strategy-performance-review-outlook2021-09-09T20:03:22+02:00https://www.bellevue.ch/all-de/all/insights/warum-der-hype-um-impfstoff-aktien-noch-nicht-vorbei-ist2021-09-16T15:51:22+02:00https://www.bellevue.ch/all-de/all/insights/healthcare-observer-loesungen-wo-medikamente-an-ihre-grenzen-stossen2021-09-27T10:36:32+02:00https://www.bellevue.ch/all-de/all/insights/bellevue-medtech-services-investors-event-digitale-neurostimulationstherapien-bei-medikamentenresistenz2021-09-29T13:10:49+02:00https://www.bellevue.ch/all-de/all/insights/nachhaltige-investments-treffen-den-nerv-der-zeit2022-09-12T17:05:28+02:00https://www.bellevue.ch/all-de/all/insights/healthcare-observer-im-bestfall-drei-zugelassene-produkte-bis-ende-20222022-09-12T17:06:37+02:00https://www.bellevue.ch/all-de/all/insights/das-wachstum-wird-beeindrucken2022-09-12T17:16:54+02:00https://www.bellevue.ch/all-de/all/insights/favoriten-fuer-spekulative-anleger2021-10-04T16:04:41+02:00https://www.bellevue.ch/all-de/all/insights/dynamische-nebenwerte-mit-guten-performanceaussichten2022-09-12T17:10:03+02:00https://www.bellevue.ch/all-de/all/insights/healthcare-observer-sector-review2021-10-06T09:38:41+02:00https://www.bellevue.ch/all-de/all/insights/entrepreneur-swiss-small-and-mid-update-mit-lead-portfoliomanagerin-birgitte-olsen2022-09-12T17:16:54+02:00https://www.bellevue.ch/all-de/all/insights/bellevue-asset-management-lanciert-bellevue-global-income-lux-fonds2022-09-12T17:20:57+02:00https://www.bellevue.ch/all-de/all/insights/bellevue-insights-healthcare-asia-emerging-markets2022-09-12T17:20:57+02:00https://www.bellevue.ch/all-de/all/insights/mit-ki-methoden-entwicklungskandidaten-identifizieren2022-09-12T17:20:14+02:00https://www.bellevue.ch/all-de/all/insights/bellevue-healthcare-outlook-innovative-therapieansaetze-im-biotech-und-medtechsektor2021-10-14T09:52:39+02:00https://www.bellevue.ch/all-de/all/insights/familienunternehmen-sind-vorreiter-in-sachen-nachhaltigkeit2021-10-20T14:54:28+02:00https://www.bellevue.ch/all-de/all/insights/bb-biotech-gewinnrealisierungen-infolge-der-covid-19-impfauffrischungs-neuigkeiten-ermoeglichen-aufstockung-in-onkologie-und-zns2021-10-26T10:49:31+02:00https://www.bellevue.ch/all-de/all/insights/private-equity-versprechen-eingehalten2022-05-25T15:25:45+02:00https://www.bellevue.ch/all-de/all/insights/viele-schweizer-wachstumsstories-kommen-nicht-an-die-boerse2021-11-09T10:49:18+01:00https://www.bellevue.ch/all-de/all/insights/die-kunst-den-richtigen-asset-manager-zu-waehlen2022-05-25T15:27:10+02:00https://www.bellevue.ch/all-de/all/insights/bellevue-healthcare-livestream2021-11-12T10:41:30+01:00https://www.bellevue.ch/all-de/all/insights/die-wahren-boersenstars2021-11-18T17:21:16+01:00https://www.bellevue.ch/all-de/all/insights/abseits-der-klassischen-boersen2022-05-25T15:27:10+02:00https://www.bellevue.ch/all-de/all/insights/investoren-update-bellevue-healthcare-strategy-lux2021-11-18T17:23:22+01:00https://www.bellevue.ch/all-de/all/insights/konsequente-ausrichtung-auf-nachhaltigkeit2021-11-22T09:40:17+01:00https://www.bellevue.ch/all-de/all/insights/konsequente-nachhnamensaenderung-bb-entrepreneur-europe2021-11-26T08:24:09+01:00https://www.bellevue.ch/all-de/all/insights/investoren-update-bellevue-sustainable-healthcare-lux2021-11-30T16:19:31+01:00https://www.bellevue.ch/all-de/all/insights/bellevue-insights-digital-health2021-12-02T08:53:03+01:00https://www.bellevue.ch/all-de/all/insights/bellevue-insights-medtech-and-services2021-12-02T13:33:58+01:00https://www.bellevue.ch/all-de/all/insights/schweizer-kmu-sind-nicht-an-der-boerse-zu-finden2021-12-07T13:55:07+01:00https://www.bellevue.ch/all-de/all/insights/birgitte-olsen-gespraech-im-rahmen-der-fng-siegel-vergabe-november-20212022-05-25T15:30:35+02:00https://www.bellevue.ch/all-de/all/insights/bb-biotech-krebsmedizin-verbessert-heilungschancen2021-12-16T08:50:39+01:00https://www.bellevue.ch/all-de/all/insights/birgitte-olsen-die-schweiz-belegt-platz-162022-05-25T15:30:35+02:00https://www.bellevue.ch/all-de/all/insights/investieren-in-digital-health-der-zeitpunkt-ist-gut2021-12-14T15:07:47+01:00https://www.bellevue.ch/all-de/all/insights/hohe-investorennachfrage-drittes-closing-des-bb-entrepreneur-private-fonds-erfolgt2021-12-22T08:51:36+01:00https://www.bellevue.ch/all-de/all/insights/medtech-services-wachstumschancen-ungebrochen2022-01-28T09:12:20+01:00https://www.bellevue.ch/all-de/all/insights/birgitte-olsen-eine-normalisierung-der-zinsen-und-der-inflation-ist-wuenschenswert2022-05-25T15:30:35+02:00https://www.bellevue.ch/all-de/all/insights/healthcare-observer-ein-weites-universum-an-kurstreibern2022-02-08T14:50:07+01:00https://www.bellevue.ch/all-de/all/insights/gesundheitsaktien-koennen-2022-eine-comebackstory-schreiben2022-02-08T10:40:42+01:00https://www.bellevue.ch/all-de/all/insights/wachstum-im-gesundheitssektor2022-02-10T09:47:09+01:00https://www.bellevue.ch/all-de/all/insights/bb-biotech-kommt-2022-die-aufholjagd-obwohl-der-auftakt-gehoerig-misslang2022-02-17T10:46:30+01:00https://www.bellevue.ch/all-de/all/insights/digital-health-2022-historisch-tiefe-bewertung-als-chance-fuer-anleger2022-03-15T16:50:55+01:00https://www.bellevue.ch/all-de/all/insights/biotech-perle-mit-kurspotenzial-biotech-sektor-ist-nicht-nur-biontech-und-novavax2022-03-15T16:55:28+01:00https://www.bellevue.ch/all-de/all/insights/bb-biotech-interview-mit-daniel-koller2022-03-15T16:50:55+01:00https://www.bellevue.ch/all-de/all/insights/bb-biotech-moderna-war-und-bleibt-ein-enorm-erfolgreiches-investment2022-03-15T16:55:28+01:00https://www.bellevue.ch/all-de/all/insights/chinas-gesundheitsindustrie-am-wendepunkt2022-03-15T16:50:55+01:00https://www.bellevue.ch/all-de/all/insights/normalisierung-nach-der-euphorie-gesundheitssektor-im-fokus2022-03-16T08:31:38+01:00https://www.bellevue.ch/all-de/all/insights/die-meisten-wurden-sehr-kalt-erwischt2022-03-17T10:00:56+01:00https://www.bellevue.ch/all-de/all/insights/medizintechnik-investieren-in-einen-chancenreichen-zukunftsmarkt2022-03-22T08:06:45+01:00https://www.bellevue.ch/all-de/all/insights/bb-biotech-unterschaetzte-biotech-neulinge2022-03-30T09:44:32+02:00https://www.bellevue.ch/all-de/all/insights/digitalisierung-des-gesundheitswesen2022-03-31T14:03:26+02:00https://www.bellevue.ch/all-de/all/insights/digital-health-im-jahr-20222022-09-12T16:33:48+02:00https://www.bellevue.ch/all-de/all/insights/marktkommentar-unterschaetzte-newcomer2022-05-24T08:59:03+02:00https://www.bellevue.ch/all-de/all/insights/bellevue-erweitert-das-management-der-entrepreneur-fonds-um-zwei-co-lead-positionen2022-04-13T08:05:39+02:00https://www.bellevue.ch/all-de/all/insights/biotech-aktien-abgestraft-zu-unrecht2022-04-19T10:19:12+02:00https://www.bellevue.ch/all-de/all/insights/medtech-and-services-normalisierung-des-operationsvolumens-wirkt-sich-positiv-aus2022-04-26T11:11:37+02:00https://www.bellevue.ch/all-de/all/insights/digital-health-ermutigende-firmenspezifische-nachrichten2022-04-26T11:14:33+02:00https://www.bellevue.ch/all-de/all/insights/bb-biotech-im-platow-special-renditechancen-20222022-04-26T14:09:09+02:00https://www.bellevue.ch/all-de/all/insights/eine-restrukturierung-waere-ein-armutszeugnis2022-05-25T15:35:57+02:00https://www.bellevue.ch/all-de/all/insights/wann-wenn-nicht-jetzt-investieren-in-eigentuemergefuehrte-unternehmen-bringt-stabilitaet-und-wachstumschancen2022-05-11T17:00:16+02:00https://www.bellevue.ch/all-de/all/insights/der-natural-fit2022-09-14T12:26:59+02:00https://www.bellevue.ch/all-de/all/insights/die-besten-fonds-fuer-globale-gesundheitsaktien2022-05-16T11:09:52+02:00https://www.bellevue.ch/all-de/all/insights/familienunternehmen-trotzen-der-krise2022-05-25T15:30:35+02:00https://www.bellevue.ch/all-de/all/insights/bellevue-african-opportunities-update2024-07-29T16:06:04+02:00https://www.bellevue.ch/all-de/all/insights/kuenstliche-intelligenz-schafft-neue-grundlagen2022-09-12T16:26:11+02:00https://www.bellevue.ch/all-de/all/insights/healthcare-observer-schluesselerfolge-jenseits-von-alzheimer2022-06-02T11:36:58+02:00https://www.bellevue.ch/all-de/all/insights/disruptive-technologien-veraendern-einen-ganzen-sektor2022-06-02T11:36:11+02:00https://www.bellevue.ch/all-de/all/insights/kapitalmarktstudie-optionspraemien-als-defensive-ertragsquelle2024-07-29T16:12:41+02:00https://www.bellevue.ch/all-de/all/insights/vielfalt-im-gesundheitssektor-nutzen2022-06-07T09:07:34+02:00https://www.bellevue.ch/all-de/all/insights/bellevue-am-experten-healthcare-chancen-sind-ungebrochen2022-09-12T16:14:47+02:00https://www.bellevue.ch/all-de/all/insights/bellevue-insights-entrepreneur-strategien2022-09-12T16:09:00+02:00https://www.bellevue.ch/all-de/all/insights/afrikanische-aktienmaerkte-treten-aus-dem-schatten-der-industrielaender2024-07-29T15:51:57+02:00https://www.bellevue.ch/all-de/all/insights/kritischer-umgang-mit-esg-ratings2022-06-17T08:48:07+02:00https://www.bellevue.ch/all-de/all/insights/bellevue-insights-asia-pacific-healthcare2022-06-20T16:45:29+02:00https://www.bellevue.ch/all-de/all/insights/bellevue-insights-emerging-markets-healthcare2022-06-20T16:49:48+02:00https://www.bellevue.ch/all-de/all/insights/boersenwissen-2022-investieren-in-den-megatrend-gesundheit2022-09-14T11:50:40+02:00https://www.bellevue.ch/all-de/all/insights/bb-biotech-investmentchef-daniel-koller-sieht-die-pharmabranche-vor-einer-uebernahmewelle-im-herbst2022-07-04T08:35:33+02:00https://www.bellevue.ch/all-de/all/insights/afrika-krisenkontinent-und-zukunftsmarkt2024-07-29T15:51:57+02:00https://www.bellevue.ch/all-de/all/insights/begehrte-innovationstreiber2022-09-14T11:46:52+02:00https://www.bellevue.ch/all-de/all/insights/virtual-deep-dive-chronische-schlafstoerungen2022-07-08T08:22:49+02:00https://www.bellevue.ch/all-de/all/insights/mehr-als-nur-rohstoffe-diese-chancen-bieten-sich-anlegern-in-afrika2024-07-29T15:54:41+02:00https://www.bellevue.ch/all-de/all/insights/familienunternehmen-haben-einen-langen-atem2022-07-15T11:03:51+02:00https://www.bellevue.ch/all-de/all/insights/bellevue-diversified-healthcare-pharma-und-biotech-favorisiert2022-07-20T11:17:27+02:00https://www.bellevue.ch/all-de/all/insights/bellevue-healthcare-strategy-garp-steht-vor-dem-comeback2022-07-20T11:15:26+02:00https://www.bellevue.ch/all-de/all/insights/bellevue-sustainable-healthcare-nachhaltigkeitsbewertung-auf-triple-a-gestiegen2022-07-27T11:11:30+02:00https://www.bellevue.ch/all-de/all/insights/inflation-neue-virusvarianten-und-ukrainekrieg-andre-rueegg-im-interview-mit-moneycab2022-09-12T15:04:33+02:00https://www.bellevue.ch/all-de/all/insights/bellevue-lux-sicav-ist-neuer-sponsor-der-sparkassen-plattform-bis-on-wms2022-07-27T11:10:01+02:00https://www.bellevue.ch/all-de/all/insights/video-update-bb-biotech-q2-20222022-09-14T11:32:59+02:00https://www.bellevue.ch/all-de/all/insights/duerfen-wir-vorstellen-gerit-heinz2022-08-08T11:28:19+02:00https://www.bellevue.ch/all-de/all/insights/wir-planen-gezielt-komplementaere-nischenstrategien2024-07-29T16:49:45+02:00https://www.bellevue.ch/all-de/all/insights/asiens-gesundheitsmarkt-waechst-in-rasantem-tempo2022-08-23T16:08:37+02:00https://www.bellevue.ch/all-de/all/insights/der-bellevue-sustainable-healthcare-fonds-unter-der-lupe-in-der-vermoegensverwalter-kolumne-von-finanzen-net2022-08-26T14:09:22+02:00https://www.bellevue.ch/all-de/all/insights/afrikas-maerkte-reagieren-verzoegert-auf-globale-faktoren2024-07-29T15:51:57+02:00https://www.bellevue.ch/all-de/all/insights/bellevue-biotech-podcast2022-09-05T10:50:18+02:00https://www.bellevue.ch/all-de/all/insights/moderna-war-erst-der-anfang2022-09-09T17:16:31+02:00https://www.bellevue.ch/all-de/all/insights/grosser-uebernahmeappetit2022-08-31T17:34:12+02:00https://www.bellevue.ch/all-de/all/insights/medtech-services-sektor-wird-seinem-ruf-gerecht2022-09-12T15:30:28+02:00https://www.bellevue.ch/all-de/all/insights/wir-schleifen-am-eigenen-haus2022-09-05T11:52:48+02:00https://www.bellevue.ch/all-de/all/insights/der-gesundheitssektor-zeichnet-sich-durch-starke-innovationskraefte-aus2022-09-12T17:23:39+02:00https://www.bellevue.ch/all-de/all/insights/bellevue-insights-medtech-services2022-09-12T10:50:07+02:00https://www.bellevue.ch/all-de/all/insights/investments-in-biotech-unternehmen-aus-der-nische-in-die-breite2022-09-27T16:32:28+02:00https://www.bellevue.ch/all-de/all/insights/healthcare-innovationen-als-inflationsschutz2022-09-28T16:32:37+02:00https://www.bellevue.ch/all-de/all/insights/healthcare-observer-die-kauflust-steigt2022-09-29T09:33:11+02:00https://www.bellevue.ch/all-de/all/insights/kuer-der-besten-fondsgesellschaften2022-09-29T13:53:45+02:00https://www.bellevue.ch/all-de/all/insights/der-unterschaetzte-kontinent-welche-chancen-afrika-fuer-investoren-bietet2024-07-29T15:53:50+02:00https://www.bellevue.ch/all-de/all/insights/kombitherapien-werden-immer-wichtiger2022-10-03T13:52:03+02:00https://www.bellevue.ch/all-de/all/insights/bellevue-biotech-alzheimer-news2022-10-04T11:00:57+02:00https://www.bellevue.ch/all-de/all/insights/digitales-diabetesmanagement-eine-erfolgsgeschichte-fuer-patienten-und-investoren2022-10-07T11:04:25+02:00https://www.bellevue.ch/all-de/all/insights/m-a-transaktionen-im-biotech-sektor-nehmen-zu2022-10-10T11:57:31+02:00https://www.bellevue.ch/all-de/all/insights/diabetes-ein-thema-fuer-investoren2022-10-25T17:11:57+02:00https://www.bellevue.ch/all-de/all/insights/biotech-investitionen-mrna-und-genom-editierung2022-11-03T14:37:45+01:00https://www.bellevue.ch/all-de/all/insights/biotech-die-aussichten-sind-vielversprechend2022-11-09T08:08:09+01:00https://www.bellevue.ch/all-de/all/insights/bellevue-african-opportunities-erkenntnisse-aus-aktuellen-unternehmensbesuchen2024-07-29T15:56:44+02:00https://www.bellevue.ch/all-de/all/insights/healthcare-aktienfonds-stabilitaet-und-sicherheit-bei-kraenkelnder-boerse2022-11-11T08:49:02+01:00https://www.bellevue.ch/all-de/all/insights/biotech-gesundes-wachstum2022-11-15T14:53:19+01:00https://www.bellevue.ch/all-de/all/insights/jede-neue-krise-ist-immer-die-schlimmste2022-11-14T13:23:50+01:00https://www.bellevue.ch/all-de/all/insights/healthcare-investments-in-ost-west2023-02-24T16:03:26+01:00https://www.bellevue.ch/all-de/all/insights/afrika-investments-solide-fundamentaldaten-stehen-im-kontrast-zu-niedriger-bewertung2024-07-29T15:51:57+02:00https://www.bellevue.ch/all-de/all/insights/die-boerse-beginnt-den-biotech-sektor-wiederzuentdecken2022-11-30T10:49:35+01:00https://www.bellevue.ch/all-de/all/insights/auf-diese-schweizer-aktien-setzt-fondsmanagerin-birgitte-olsen2022-12-05T10:40:10+01:00https://www.bellevue.ch/all-de/all/insights/wachstum-dank-innovation-nachhaltige-dynamik-im-biotechsektor2022-12-06T15:57:36+01:00https://www.bellevue.ch/all-de/all/insights/molekulare-eingreiftruppen-fuer-das-immunsystem2022-12-07T17:33:25+01:00https://www.bellevue.ch/all-de/all/insights/management-talk-eine-bellevue-entrepreneur-serie2022-12-14T08:18:08+01:00https://www.bellevue.ch/all-de/all/insights/us-arzneibehoerde-vergibt-beschleunigte-zulassung-fuer-alzheimer-medikament2023-01-09T14:12:16+01:00https://www.bellevue.ch/all-de/all/insights/renaissance-der-anleihen-und-multi-asset-fonds-im-jahr-20232023-01-23T13:17:15+01:00https://www.bellevue.ch/all-de/all/insights/ein-fels-in-der-brandung2023-01-23T13:16:49+01:00https://www.bellevue.ch/all-de/all/insights/marktausblick-20232023-01-23T13:17:45+01:00https://www.bellevue.ch/all-de/all/insights/die-langfristigen-wachstumsfaktoren-sind-intakt2023-01-23T15:53:39+01:00https://www.bellevue.ch/all-de/all/insights/fuenf-opportunitaeten-fuer-healthcare-investoren2023-01-24T16:32:55+01:00https://www.bellevue.ch/all-de/all/insights/kurswechsel2023-02-06T08:41:32+01:00https://www.bellevue.ch/all-de/all/insights/schrammt-die-wirtschaft-doch-noch-an-einer-rezession-vorbei2024-07-29T16:10:26+02:00https://www.bellevue.ch/all-de/all/insights/regionale-healthcare-strategien-china-im-fokus2024-07-29T16:22:06+02:00https://www.bellevue.ch/all-de/all/insights/srf-milliardengeschaeft-diabetes2023-01-30T15:32:41+01:00https://www.bellevue.ch/all-de/all/insights/healthcare-observer-grosser-durchbruch-fuer-die-alzheimerbehandlung2023-02-02T09:38:41+01:00https://www.bellevue.ch/all-de/all/insights/veraenderter-kurs-an-den-aktienmaerkten2023-02-02T16:19:55+01:00https://www.bellevue.ch/all-de/all/insights/ideales-umfeld-fuer-optionsstrategien2023-02-14T17:26:53+01:00https://www.bellevue.ch/all-de/all/insights/wir-erwarten-fuer-die-kommenden-quartale-eine-zunahme-der-uebernahmeaktivitaet2023-03-03T14:57:47+01:00https://www.bellevue.ch/all-de/all/insights/comeback-der-globalen-gesundheitsmaerkte2023-02-21T17:40:33+01:00https://www.bellevue.ch/all-de/all/insights/ard-afrika-investments-warum-afrika-fuer-investoren-interessant-sein-koennte2024-07-29T15:51:57+02:00https://www.bellevue.ch/all-de/all/insights/management-talk-ii-eine-bellevue-entrepreneur-serie2023-03-10T16:38:54+01:00https://www.bellevue.ch/all-de/all/insights/diversifikation-spielt-eine-wichtige-rolle-fuer-den-unternehmenswert2023-03-10T10:39:47+01:00https://www.bellevue.ch/all-de/all/insights/inflation-langsam-wird-es-zaeh2023-03-13T08:23:36+01:00https://www.bellevue.ch/all-de/all/insights/ard-update-wirtschaft-mit-gerit-heinz2023-03-29T11:36:48+02:00https://www.bellevue.ch/all-de/all/insights/irgendwann-muss-man-ins-medizinische-ersatzteillager-greifen-gesundheit-waechst-doppelt-so-stark2023-03-30T16:47:12+02:00https://www.bellevue.ch/all-de/all/insights/5-gruende-fuer-optionsstrategien2023-04-03T09:30:10+02:00https://www.bellevue.ch/all-de/all/insights/marktentwicklungen-was-kommt-auf-die-anleger-zu2024-12-12T10:21:21+01:00https://www.bellevue.ch/all-de/all/insights/ein-bisschen-inflation-verhindert-dass-man-dumme-sachen-macht2023-04-04T13:43:56+02:00https://www.bellevue.ch/all-de/all/insights/moderna-ist-auf-gutem-weg-eines-der-grossen-pharmaunternehmen-zu-werden2023-04-12T10:17:13+02:00https://www.bellevue.ch/all-de/all/insights/veraenderung-ist-die-einzige-konstante2023-04-13T14:53:11+02:00https://www.bellevue.ch/all-de/all/insights/man-zahlt-nicht-mehr-so-viel-fuer-zukunftsmusik2024-07-29T16:48:59+02:00https://www.bellevue.ch/all-de/all/insights/gerit-heinz-im-interview-mit-finance-news-tv2024-12-12T10:18:27+01:00https://www.bellevue.ch/all-de/all/insights/mit-algorithmen-zu-blockbustern2023-05-05T14:12:00+02:00https://www.bellevue.ch/all-de/all/insights/smart-investor-bellevue-entrepreneur-swiss-small-mid2023-05-08T15:28:15+02:00https://www.bellevue.ch/all-de/all/insights/bei-gesundheitsaktien-werden-wir-staerkeres-wachstum-sehen2023-06-06T11:03:07+02:00https://www.bellevue.ch/all-de/all/insights/bellevue-blickpunkt-zurueck-zur-sorglosigkeit2023-05-30T08:48:07+02:00https://www.bellevue.ch/all-de/all/insights/ertraege-plus-absicherung2023-05-15T15:55:14+02:00https://www.bellevue.ch/all-de/all/insights/fondsconsult-medtech-services-der-nachhaltige-outperformer2023-05-15T15:21:42+02:00https://www.bellevue.ch/all-de/all/insights/zurueck-zur-sorglosigkeit2023-05-23T09:06:24+02:00https://www.bellevue.ch/all-de/all/insights/wir-investieren-da-wo-innovation-am-groessten-ist2023-05-31T10:26:12+02:00https://www.bellevue.ch/all-de/all/insights/podcast-volatilitaet-die-ruhe-vor-dem-sturm2023-06-09T15:40:28+02:00https://www.bellevue.ch/all-de/all/insights/fundamental-betrachtet-zeigt-sich-der-sektor-in-guter-verfassung2023-06-06T09:24:14+02:00https://www.bellevue.ch/all-de/all/insights/investieren-mit-weitblick-innovationen-in-der-augenheilkunde2023-06-20T14:19:20+02:00https://www.bellevue.ch/all-de/all/insights/healthcare-observer-durchbruch-bei-schwerer-augenerkrankung2023-06-22T09:58:31+02:00https://www.bellevue.ch/all-de/all/insights/vorbeugen-ist-besser-als-heilen2023-06-22T14:02:36+02:00https://www.bellevue.ch/all-de/all/insights/die-frau-die-aus-der-kaelte-kam2023-06-26T16:40:46+02:00https://www.bellevue.ch/all-de/all/insights/scharfer-blick-zeigt-die-chancen-der-biotechs2023-07-11T10:57:11+02:00https://www.bellevue.ch/all-de/all/insights/sommergruesse-aus-sao-paulo2024-07-29T16:20:18+02:00https://www.bellevue.ch/all-de/all/insights/optionsstrategien-sind-vor-dem-hintergrund-der-unsicheren-kapitalmaerkte-eine-attraktive-anlageform2023-07-18T09:47:47+02:00https://www.bellevue.ch/all-de/all/insights/vorstoss-ins-healthcare-universum-rueck-und-ausblick2023-08-09T15:43:42+02:00https://www.bellevue.ch/all-de/all/insights/wir-blicken-zuversichtlich-auf-das-2-halbjahr2023-08-04T11:36:50+02:00https://www.bellevue.ch/all-de/all/insights/healthcare-eine-chance-fuer-antizykliker2023-08-09T15:12:28+02:00https://www.bellevue.ch/all-de/all/insights/wir-wuerden-bei-swatch-die-weitergabe-an-die-erweiterte-familie-begruessen2023-08-23T14:20:53+02:00https://www.bellevue.ch/all-de/all/insights/schweizer-nebenwerte-sind-jetzt-sehr-attraktiv2023-08-31T11:24:00+02:00https://www.bellevue.ch/all-de/all/insights/geschrumpfter-finanzplatz-hoehere-zinsen-wie-weiter2023-09-11T15:09:48+02:00https://www.bellevue.ch/all-de/all/insights/comeback-fuer-infrastrukturinvestitionen-der-megatrend-fuer-die-naechste-dekade-und-welche-unternehmen-davon-profitieren2023-09-11T14:39:05+02:00https://www.bellevue.ch/all-de/all/insights/cyrill-zimmermann-bellevue-am-die-bewertungen-sind-tatsaechlich-sehr-attraktiv2023-09-20T09:43:22+02:00https://www.bellevue.ch/all-de/all/insights/kuenstliche-intelligenz-im-gesundheitswesen2023-09-15T16:02:14+02:00https://www.bellevue.ch/all-de/all/insights/ueberalterung-und-wachsender-wohlstand-treiben-nachfrage-im-healthcaresektor2023-09-20T09:43:47+02:00https://www.bellevue.ch/all-de/all/insights/bellevue-option-premium-alternative-performance2023-10-03T16:09:43+02:00https://www.bellevue.ch/all-de/all/insights/finanzierung-von-biotechinnovationen2023-10-04T08:24:17+02:00https://www.bellevue.ch/all-de/all/insights/bis-jetzt-war-es-ein-bisschen-wie-warten-auf-godot2023-10-12T14:02:47+02:00https://www.bellevue.ch/all-de/all/insights/nachhaltigkeit-lohnt-auch-im-gesundheitswesen2023-10-31T14:34:48+01:00https://www.bellevue.ch/all-de/all/insights/healthcare-investments-in-ost-west-entwicklungen-und-trends2023-11-10T15:26:13+01:00https://www.bellevue.ch/all-de/all/insights/die-ergebnisse-der-select-studie-sind-ein-wendepunkt-fuer-die-behandlung-fettleibiger-patienten-mit-kardiovaskulaeren-vorerkrankungen2023-11-13T08:47:24+01:00https://www.bellevue.ch/all-de/all/insights/auf-jeden-fall-ein-gamechanger2024-07-29T17:29:17+02:00https://www.bellevue.ch/all-de/all/insights/kommt-schon-bald-eine-zinssenkung2023-11-28T14:25:35+01:00https://www.bellevue.ch/all-de/all/insights/bewaeltigung-der-adipositas-pandemie-gewinnt-an-dynamik2024-07-29T17:27:05+02:00https://www.bellevue.ch/all-de/all/insights/bb-biotechs-koller-this-crash-will-look-like-a-blip2023-12-05T11:34:36+01:00https://www.bellevue.ch/all-de/all/insights/steht-ein-rebound-von-small-mid-caps-an2023-12-05T16:17:25+01:00https://www.bellevue.ch/all-de/all/insights/fettleibigkeit-loest-goldrausch-aus2024-07-29T17:27:27+02:00https://www.bellevue.ch/all-de/all/insights/nutzung-von-big-data-und-ki-zur-identifizierung-von-kuenftigen-biotech-marktfuehrern2023-12-12T12:22:45+01:00https://www.bellevue.ch/all-de/all/insights/stockwaves-tischgespraech-aktienmaerkte-ausserhalb-der-eu2023-12-13T13:56:55+01:00https://www.bellevue.ch/all-de/all/insights/healthcare-observer-fettleibigkeit-wird-auch-fuer-investoren-immer-gewichtiger2023-12-14T09:49:45+01:00https://www.bellevue.ch/all-de/all/insights/steht-eine-trendwende-bei-small-und-mid-caps-an2023-12-18T16:08:03+01:00https://www.bellevue.ch/all-de/all/insights/beteiligungsgesellschaften-early-cycle-einstiegschance-bei-bb-biotech-und-hbm-healthcare2023-12-19T10:26:18+01:00https://www.bellevue.ch/all-de/all/insights/gesundheitssektor-vor-dem-comeback2023-12-19T16:38:00+01:00https://www.bellevue.ch/all-de/all/insights/auszeichnung-fuer-dynamic-bonds-fonds2024-01-29T14:20:50+01:00https://www.bellevue.ch/all-de/all/insights/jahrtausendinnovation-ist-in-vollem-schwung2024-07-29T17:27:27+02:00https://www.bellevue.ch/all-de/all/insights/bb-biotech-video-update-insights-highlights-und-ausblick2024-02-08T14:39:16+01:00https://www.bellevue.ch/all-de/all/insights/bellevue-blickpunkt-hoffnung-auf-die-weiche-landung2024-12-12T10:12:24+01:00https://www.bellevue.ch/all-de/all/insights/medizintechniksektor-zurueck-auf-erfolgskurs2024-03-01T16:29:59+01:00https://www.bellevue.ch/all-de/all/insights/das-thema-fettleibigkeit-erfordert-einen-ganzheitlichen-ansatz2024-07-29T17:23:41+02:00https://www.bellevue.ch/all-de/all/insights/der-kampf-gegen-uebergewicht-dr-christian-lach-und-der-bellevue-obesity-solutions-fonds-im-fokus2024-03-05T08:02:01+01:00https://www.bellevue.ch/all-de/all/insights/biochemiker-und-fondsmanager-dr-lukas-leu-ueber-die-verbindung-von-wissenschaft-geldanlage2024-03-07T11:36:10+01:00https://www.bellevue.ch/all-de/all/insights/der-biotech-sektor-steht-vor-einer-wiederbelebung2024-03-05T09:09:43+01:00https://www.bellevue.ch/all-de/all/insights/rendite-mit-gesundheit-12024-03-11T10:16:28+01:00https://www.bellevue.ch/all-de/all/insights/viel-bewegung-auf-dem-markt-fuer-medikamente-zur-gewichtsabnahme2024-07-29T17:21:11+02:00https://www.bellevue.ch/all-de/all/insights/nach-dem-zinsentscheid2024-03-25T14:38:33+01:00https://www.bellevue.ch/all-de/all/insights/daenemarks-zweite-novo-nordisk2024-07-29T17:21:11+02:00https://www.bellevue.ch/all-de/all/insights/wir-sind-ueberzeugt-dass-small-und-mid-caps-zu-den-outperformern-zaehlen-werden2024-04-08T08:20:10+02:00https://www.bellevue.ch/all-de/all/insights/das-kann-weitreichende-konsequenzen-fuer-bestehende-pharmakonzerne-haben2024-04-09T08:57:39+02:00https://www.bellevue.ch/all-de/all/insights/bellevue-entrepreneur-europe-small-wird-als-top-fonds-ausgezeichnet2024-07-29T17:21:11+02:00https://www.bellevue.ch/all-de/all/insights/blickpunkt-und-immer-noch-warten2024-04-18T14:31:38+02:00https://www.bellevue.ch/all-de/all/insights/auf-diesem-gebiet-herrscht-jetzt-aufbruchstimmung2024-07-29T17:21:11+02:00https://www.bellevue.ch/all-de/all/insights/fondsanalyse-bellevue-entrepreneur-europe-small2024-05-27T11:37:29+02:00https://www.bellevue.ch/all-de/all/insights/investitionen-in-wachstumsstarke-biotechnologie-unternehmen-mit-dr-daniel-koller-von-bb-biotech2024-05-13T14:51:34+02:00https://www.bellevue.ch/all-de/all/insights/ai-health-es-ist-zentral-dass-man-zu-den-ersten-gehoert2024-07-29T17:13:44+02:00https://www.bellevue.ch/all-de/all/insights/bellevue-nachgefragt-stehen-multi-asset-strategien-vor-dem-comeback2024-05-29T11:21:15+02:00https://www.bellevue.ch/all-de/all/insights/argenx-im-spotlight2024-06-07T10:53:23+02:00https://www.bellevue.ch/all-de/all/insights/der-einfluss-von-algorithmen-und-big-data-auf-die-entwicklung-neuer-arzneimittel-eine-empirische-erhebung2024-06-12T13:46:32+02:00https://www.bellevue.ch/all-de/all/insights/unternehmen-wie-meyer-burger-sind-fuer-uns-eher-spekulative-wetten2024-07-29T17:13:07+02:00https://www.bellevue.ch/all-de/all/insights/webinar-medtech-and-services-kuenstliche-intelligenz-im-gesundheitswesen-und-wie-sie-davon-profitieren2024-07-29T17:11:36+02:00https://www.bellevue.ch/all-de/all/insights/healthcare-observer-generative-ki-eroeffnet-neue-investitionsperspektiven2024-06-27T13:54:31+02:00https://www.bellevue.ch/all-de/all/insights/groesste-medikamentenklasse-ist-am-entstehen2024-07-29T17:16:56+02:00https://www.bellevue.ch/all-de/all/insights/40-der-erwachsenen-in-den-usa-haben-das-ckm-syndrom2024-07-04T09:37:14+02:00https://www.bellevue.ch/all-de/all/insights/multi-asset-steht-vor-einer-renaissance2024-07-04T11:12:07+02:00https://www.bellevue.ch/all-de/all/insights/neue-blockbustermaerkte-im-medizintechniksektor2024-07-04T16:51:51+02:00https://www.bellevue.ch/all-de/all/insights/die-neuen-player-in-der-medikamentenentwicklung-gegen-fettleibigkeit2024-07-29T17:16:56+02:00https://www.bellevue.ch/all-de/all/insights/novo-nordisk-landet-auf-platz-eins-im-innovation-index-2024-von-idea-pharma2024-12-12T17:01:17+01:00https://www.bellevue.ch/all-de/all/insights/klare-strategien-und-hohes-wachstumspotenzial-dank-kuenstlicher-intelligenz2024-07-29T17:14:46+02:00https://www.bellevue.ch/all-de/all/insights/3-jahre-bellevue-option-premium-erfolgreiche-volatilitaetsstrategie-fuer-risiko-und-renditeoptimierung2024-08-08T15:05:43+02:00https://www.bellevue.ch/all-de/all/insights/analyse-trifft-auf-intuition2024-07-29T17:07:32+02:00https://www.bellevue.ch/all-de/all/insights/der-ukraine-krieg-hat-tiefe-wunden-im-europaeischen-aktienmarkt-hinterlassen-die-noch-nicht-verheilt-sind2024-08-12T14:42:37+02:00https://www.bellevue.ch/all-de/all/insights/auf-diese-gesundheits-aktien-setzt-portfolio-manager-terence-mc-manus-abseits-von-novo-nordisk-und-eli-lilly2024-08-06T14:10:06+02:00https://www.bellevue.ch/all-de/all/insights/wir-erachten-kmus-als-sehr-interessante-investitionsmoeglichkeit-mit-attraktiven-renditepotenzial2024-09-06T16:09:21+02:00https://www.bellevue.ch/all-de/all/insights/demografie-und-ai-treiben-medtech-aktien2024-10-04T15:59:07+02:00https://www.bellevue.ch/all-de/all/insights/highlights-aus-15-jahren-bellevue-medtech-and-services2024-10-08T14:48:21+02:00https://www.bellevue.ch/all-de/all/insights/fortschritte-bei-hoergeraeten-durch-ki2024-11-25T08:27:04+01:00https://www.bellevue.ch/all-de/all/insights/neue-kurspotenziale-fuer-pharmaunternehmen2024-10-18T14:48:59+02:00https://www.bellevue.ch/all-de/all/insights/pharmaaktien-in-china-leiden2024-10-29T10:52:55+01:00https://www.bellevue.ch/all-de/all/insights/ozempic-reduziert-womoeglich-das-alzheimerrisiko2024-11-26T08:19:23+01:00https://www.bellevue.ch/all-de/all/insights/ai-koennte-aus-einem-offenen-markt-einen-the-winner-takes-it-all-markt-machen2024-10-31T11:28:56+01:00https://www.bellevue.ch/all-de/all/insights/grosse-fische-im-datenmeer-warum-ki-im-gesundheitssektor-die-grossen-bevorzugt2024-11-11T17:29:03+01:00https://www.bellevue.ch/all-de/all/insights/novo-nordisk-abnehmspritzen-sind-gefragter-als-die-der-konkurrenz2024-11-19T16:10:06+01:00https://www.bellevue.ch/all-de/all/insights/early-tavr-warten-ist-nicht-von-vorteil2024-12-12T16:59:40+01:00https://www.bellevue.ch/all-de/all/insights/medtech-im-fokus-historische-outperformance-in-phasen-sinkender-zinsen2024-11-26T16:37:55+01:00https://www.bellevue.ch/all-de/all/insights/der-markt-fuer-loesungen-gegen-uebergewicht-boomt2024-12-02T17:40:20+01:00https://www.bellevue.ch/all-de/all/insights/was-kommt-2025-healthcare-investments-nach-der-us-wahl2024-12-16T13:01:32+01:00https://www.bellevue.ch/all-de/all/insights/gewichtige-chancen-investieren-in-den-fortschritt-der-uebergewichtsbehandlung2024-12-09T11:02:12+01:00https://www.bellevue.ch/all-de/all/insights/der-gesundheitssektor-groesste-chancen-fuer-aktives-portfolio-management2024-12-12T16:47:41+01:00https://www.bellevue.ch/all-de/all/insights/healthcare-markt-und-trump-aufbruch-oder-risiko2024-12-18T08:02:32+01:00https://www.bellevue.ch/all-de/all/insights/top-tipp-fuer-2025-die-besten-gesundheitsfonds2024-12-30T10:12:45+01:00https://www.bellevue.ch/all-de/all/insights/das-sind-die-besten-aktienfonds-fuer-gesundheit-und-pharma2025-01-14T15:33:34+01:00https://www.bellevue.ch/all-de/all/insights/j-p-morgan-healthcare-konferenz-2025-uebernahmen-innovationen-und-beeindruckende-erfolge2025-01-17T10:39:42+01:00https://www.bellevue.ch/all-de/all/insights/bei-schweizer-small-caps-gibt-es-fast-nie-ein-schnaeppchen2025-02-10T15:09:28+01:00https://www.bellevue.ch/all-de/all/insights/die-game-changer-im-gesundheitssektor-20252025-02-28T10:00:52+01:00https://www.bellevue.ch/all-de/all/insights/agil-bleiben-und-diversifizieren2025-03-03T15:26:46+01:00https://www.bellevue.ch/all-de/all/insights/healthcare-ist-von-zoellen-am-wenigsten-betroffen2025-03-10T14:22:03+01:00https://www.bellevue.ch/all-de/all/insights/kleine-werte-gross-im-kommen2025-03-06T13:25:46+01:00https://www.bellevue.ch/all-de/all/insights/es-war-wie-eine-autobahn-richtung-usa2025-03-14T15:27:12+01:00https://www.bellevue.ch/all-de/all/insights/europaeische-small-caps-experten-tipps-fuer-maximale-gewinne2025-03-26T16:54:45+01:00https://www.bellevue.ch/all-de/all/insights/europa-im-aufwind-kehrt-das-anlegerinteresse-zurueck2025-04-03T07:53:03+02:00https://www.bellevue.ch/all-de/all/insights/webinar-medtech-and-services-der-nachhaltige-outperformer2025-04-09T15:28:36+02:00https://www.bellevue.ch/all-de/all/insights/waehrend-zoelle-anlass-zur-sorge-geben-glauben-wir-dass-die-mehrheit-der-gesundheitsunternehmen-ueber-das-kapital-die-flexibilitaet-und-die-margen-verfuegt-um-mit-dem-sich-wandelnden-umfeld-zurechtzukommen2025-04-16T08:59:42+02:00https://www.bellevue.ch/all-de/all/insights/warum-europaeische-small-und-mid-caps-jetzt-spannend-sind2025-04-30T11:10:09+02:00https://www.bellevue.ch/all-de/all/insights/medtech-services-innovation-als-bollwerk-gegen-politische-unsicherheit2025-05-09T07:45:27+02:00https://www.bellevue.ch/all-de/all/insights/webinar-diversified-healthcare-vom-innovationspotenzial-im-gesamten-gesundheitssektor-profitieren2025-05-21T14:52:28+02:00https://www.bellevue.ch/all-de/all/insights/dank-trump-und-vance-birgitte-olsen-sieht-aufschwung-fuer-europaeische-nebenwerte2025-06-02T17:08:03+02:00https://www.bellevue.ch/all-de/all/insights/der-direkte-einfluss-der-us-zoelle-auf-medtech-bleibt-bislang-ueberschaubar2025-06-03T14:08:37+02:00https://www.bellevue.ch/all-de/all/insights/asco-2025-kurzeinblick-in-krebstherapien-von-morgen-gefaellig2025-06-12T14:04:37+02:00https://www.bellevue.ch/all-de/all/insights/europaeische-small-mid-caps-verspeisen-granolas-zum-fruehstueck2025-06-05T08:16:57+02:00https://www.bellevue.ch/all-de/all/insights/hoehepunkte-der-ada-2025-orale-glp-1-wirkstoffe-amylin-kombinationspraeparate-muskelerhaltende-therapien-zur-behandlung-von-adipositas-und-neue-wege-in-der-diabetesversorgung2025-07-11T10:27:06+02:00https://www.bellevue.ch/all-de/all/insights/kuenstliche-intelligenz-im-gesundheitswesen-webinar2025-06-25T15:35:14+02:00https://www.bellevue.ch/all-de/all/insights/healthcare-sektor-drei-ueberzeugende-gruende-fuer-eine-neueinschaetzung2025-07-25T09:44:17+02:00https://www.bellevue.ch/all-de/all/insights/bellevue-medtech-services-auf-platz-1-erfolgreichster-aktiv-gemanagter-healthcare-fonds-ueber-10-jahre2025-07-02T14:56:51+02:00https://www.bellevue.ch/all-de/all/insights/low-valuations-looming-deals-why-bb-biotech-sees-new-cycle2025-07-14T10:01:29+02:00https://www.bellevue.ch/all-de/all/insights/wachstumschance-adipositas-investieren-in-die-gesundheit-von-morgen2025-07-15T14:11:59+02:00https://www.bellevue.ch/all-de/all/insights/biotech-im-stimmungstief-reif-fuer-ein-comeback2025-08-13T08:38:11+02:00https://www.bellevue.ch/all-de/all/insights/kuenstliche-intelligenz-kann-entwicklungszeit-neuer-medikamente-deutlich-verkuerzen2025-09-08T16:10:09+02:00https://www.bellevue.ch/all-de/all/insights/pharma-im-aufschwung-china-und-japan-treiben-innovation-und-globalen-einfluss-voran2025-09-11T14:10:24+02:00https://www.bellevue.ch/all-de/all/insights/jetzt-sehen-wir-wieder-mittelzufluesse2025-09-23T14:24:16+02:00https://www.bellevue.ch/all-de/all/insights/healthcare-vier-treiber-fuer-ein-comeback2025-09-24T07:42:38+02:00https://www.bellevue.ch/all-de/all/insights/gesundheit-trifft-rendite-weshalb-bellevue-einen-aktiven-healthcare-etf-lanciert2025-09-25T14:47:59+02:00https://www.bellevue.ch/all-de/all/insights/pfizer-trump-vereinbarung-stellt-wendepunkt-in-der-debatte-um-arzneimittelpreise-dar2025-10-03T09:26:42+02:00https://www.bellevue.ch/all-de/all/insights/europaeische-smallcaps-das-sind-die-staerksten-fonds2025-10-29T10:06:11+01:00https://www.bellevue.ch/all-de/all/insights/europaeische-small-and-mid-caps-sind-weniger-von-zollproblematiken-betroffen2025-10-28T17:21:39+01:00https://www.bellevue.ch/all-de/all/insights/gesundheitsmarkt-im-wandel-chancen-mit-dem-neuen-bellevue-healthcare-etf2025-10-30T14:25:21+01:00https://www.bellevue.ch/all-de/all/insights/wir-sehen-ein-erhebliches-aufwaertspotential-fuer-medtech-services-sektor2025-11-18T14:14:16+01:00https://www.bellevue.ch/all-de/all/insights/jefferies-healthcare-conference-2025-optimismus-praegt-die-gespraeche-mit-branchenfuehrern2025-11-20T15:53:16+01:00https://www.bellevue.ch/all-de/all/insights/gesundheitswesen-starkes-momentum-und-neue-chancen2025-11-25T14:12:56+01:00https://www.bellevue.ch/all-de/all/insights/bellevue-webinar-was-bewegt-das-healthcare-jahr-20262025-12-03T08:32:19+01:00https://www.bellevue.ch/all-de/all/insights/europa-steht-an-der-schwelle-eines-zyklischen-rebounds2025-12-03T16:45:35+01:00https://www.bellevue.ch/all-de/all/insights/5-gruende-fuer-ein-starkes-healthcare-jahr-20262025-12-16T14:30:13+01:00https://www.bellevue.ch/all-de/all/insights/drei-stock-pickers-gehen-zuversichtlich-ins-jahr-20262026-01-14T08:58:58+01:00https://www.bellevue.ch/all-de/all/insights/start-2026-starke-impulse-fuer-gesundheitsanlagen2026-01-12T14:05:02+01:00https://www.bellevue.ch/all-de/all/insights/healthcare-wird-auch-fuer-generalisten-investoren-wieder-attraktiver2026-01-15T08:49:30+01:00https://www.bellevue.ch/all-de/all/insights/j-p-morgan-healthcare-conference-impulse-fuer-eine-neubewertung-des-sektors-verdichten-sich2026-01-26T09:01:12+01:00https://www.bellevue.ch/all-de/all/insights/europa-ist-unterschaetzt-warum-eine-fondsmanagerin-jetzt-auf-small-caps-setzt2026-02-09T08:04:07+01:00https://www.bellevue.ch/all-de/all/insights/die-zukunft-der-gesundheitsversorgung2026-02-27T14:16:17+01:00https://www.bellevue.ch/all-de/all/insights/der-euroraum-generiert-positive-makrooekonomische-signale2026-03-04T13:47:41+01:00https://www.bellevue.ch/all-de/all/insights/ki-entwickelt-sich-im-gesundheitssektor-vom-narrativ-zu-messbarer-produktivitaet2026-03-06T11:50:31+01:00https://www.bellevue.ch/all-de/all/insights/medtech-services-2026-fundamentale-staerke-bei-attraktiver-bewertung2026-03-10T08:03:59+01:00https://www.bellevue.ch/all-de/all/insights/bellevue-entrepreneur-europe-small-fonds-mit-kleinen-werten-zu-grosser-rendite2026-03-20T14:42:56+01:00https://www.bellevue.ch/all-de/all/ueber-uns/was-uns-antreibt2024-06-27T16:55:44+02:00https://www.bellevue.ch/all-de/all/ueber-uns/was-uns-auszeichnet2024-06-27T16:55:44+02:00https://www.bellevue.ch/all-de/all/ueber-uns/was-uns-auszeichnet/unsere-investmentteams2025-01-09T13:47:39+01:00https://www.bellevue.ch/all-de/all/ueber-uns/was-uns-auszeichnet/unser-management2024-06-27T16:55:44+02:00https://www.bellevue.ch/all-de/all/ueber-uns/nachhaltigkeit2024-07-01T11:29:13+02:00https://www.bellevue.ch/all-de/all/ueber-uns/nachhaltigkeit/verantwortungsvolle-investitionen2024-07-01T11:31:39+02:00https://www.bellevue.ch/all-de/all/ueber-uns/nachhaltigkeit/corporate-governance2024-07-01T11:34:11+02:00https://www.bellevue.ch/all-de/all/ueber-uns/nachhaltigkeit/weisungen2024-07-01T11:35:53+02:00https://www.bellevue.ch/all-de/all/ueber-uns/kontakt-aufnehmen2024-06-27T16:55:44+02:00https://www.bellevue.ch/all-de/all/ueber-uns/kontakt-aufnehmen/unsere-standorte2024-06-27T16:55:44+02:00https://www.bellevue.ch/all-de/all/ueber-uns/kontakt-aufnehmen/karriere2024-07-01T11:09:24+02:00https://www.bellevue.ch/all-de/all/investor-relations/bellevue-aktie2021-07-31T10:46:04+02:00https://www.bellevue.ch/all-de/all/investor-relations/bellevue-aktie/unser-geschaeftsmodell2024-07-01T14:15:25+02:00https://www.bellevue.ch/all-de/all/investor-relations/bellevue-aktie/aktienkurs2022-05-17T14:31:38+02:00https://www.bellevue.ch/all-de/all/investor-relations/unternehmenskalender2021-07-31T10:47:24+02:00https://www.bellevue.ch/all-de/all/investor-relations/unternehmenskalender/generalversammlung2022-02-21T15:01:14+01:00https://www.bellevue.ch/all-de/all/investor-relations/finanzreporting2023-07-26T11:22:51+02:00https://www.bellevue.ch/all-de/all/investor-relations/corporate-news2021-12-02T15:31:13+01:00https://www.bellevue.ch/all-de/all/investor-relations/corporate-news/newsletter2024-07-01T13:50:16+02:00https://www.bellevue.ch/all-de/all/investor-relations/corporate-news/bellevues-halbjahresgewinn-marktbedingt-auf-chf-14-3-mio-reduziert-stabile-kundenbasis-dank-anerkannter-anlageexpertise2022-07-28T06:12:55+02:00https://www.bellevue.ch/all-de/all/investor-relations/corporate-news/erfolgreiches-closing-der-bellevue-entrepreneur-private-strategie-bellevue-private-markets-mit-kontinuierlichem-wachstum2022-06-20T07:03:20+02:00https://www.bellevue.ch/all-de/all/investor-relations/corporate-news/bellevue-stellt-sich-in-deutschland-neu-auf2022-06-15T07:45:50+02:00https://www.bellevue.ch/all-de/all/investor-relations/corporate-news/bellevue-erwartet-im-vorjahresvergleich-deutlich-tieferes-halbjahresresultat2022-06-14T07:00:15+02:00https://www.bellevue.ch/all-de/all/investor-relations/corporate-news/generalversammlung-der-bellevue-group-ag-alle-antraege-angenommen-42022-03-22T17:58:00+01:00https://www.bellevue.ch/all-de/all/investor-relations/corporate-news/bellevue-steigert-konzerngewinn-markant-um-93-auf-chf-43-1-mio-attraktive-dividendenpolitik-mit-beantragung-einer-erhoehung-der-dividende-auf-chf-2-702022-03-15T15:33:33+01:00https://www.bellevue.ch/all-de/all/investor-relations/corporate-news/bellevue-group-setzt-in-deutschland-zukuenftig-auf-eine-one-brand-strategie2022-03-15T15:36:46+01:00https://www.bellevue.ch/all-de/all/investor-relations/corporate-news/bellevue-mit-voraussichtlich-deutlich-gesteigertem-konzerngewinn-von-chf-43-mio-bellevue-mit-voraussichtlich-deutlich-gesteigertem-konzerngewinn-von-chf-43-mio-93-beantragung-einer-um-80-hoeheren-ordentlichen-dividende-von-chf-2-702022-06-13T14:32:09+02:00https://www.bellevue.ch/all-de/all/investor-relations/corporate-news/konsequente-nachhaltigkeitsausrichtung-und-namensaenderung-bb-entrepreneur-europe-wird-zu-bellevue-sustainable-entrepreneur-europe2022-03-15T15:33:33+01:00https://www.bellevue.ch/all-de/all/investor-relations/corporate-news/bellevue-asset-management-lanciert-bellevue-global-income-lux-fonds2022-03-15T15:36:09+01:00https://www.bellevue.ch/all-de/all/investor-relations/corporate-news/bellevue-vervierfacht-konzerngewinn-auf-chf-22-5-mio-anstieg-der-kundenvermoegen-um-20-auf-neuen-hoechststand-von-chf-14-4-mrd2022-03-15T15:33:33+01:00https://www.bellevue.ch/all-de/all/investor-relations/corporate-news/bellevue-group-mit-voraussichtlich-hoeherem-halbjahres-konzerngewinn-deutlich-hoehere-durchschnittlich-betreute-kundenvermoegen2022-06-13T14:34:03+02:00https://www.bellevue.ch/all-de/all/investor-relations/corporate-news/bellevue-group-mit-voraussichtlich-rund-60-hoeherem-konzerngewinn-von-ueber-chf-22-mio-beantragung-einer-sonderdividende-von-chf-2-502022-02-18T11:21:20+01:00https://www.bellevue.ch/all-de/all/investor-relations/corporate-news/offenlegung-von-beteiligungen-hans-joerg-wyss-uebernimmt-von-joerg-bantleon-anteil-an-bellevue-group2022-02-18T11:21:20+01:00https://www.bellevue.ch/all-de/all/investor-relations/corporate-news/bellevue-group-steigert-operatives-ergebnis-um-15-konzerngewinn-durch-sondereffekte-erheblich-geschmaelert2022-02-18T11:21:20+01:00https://www.bellevue.ch/all-de/all/investor-relations/corporate-news/korrektur-konzerngewinn-2019-von-chf-11-4-mio-auf-chf-14-0-mio2022-02-18T11:21:20+01:00https://www.bellevue.ch/all-de/all/investor-relations/corporate-news/bellevue-group-schliesst-verkauf-der-bank-an-quintet-erfolgreich-ab2022-02-18T11:21:20+01:00https://www.bellevue.ch/all-de/all/investor-relations/corporate-news/bellevue-group-mit-voraussichtlichem-operativem-ergebnis-von-ueber-chf-39-mio-beantragung-einer-sonderdividende-von-chf-2-75-pro-aktie2022-02-18T11:21:20+01:00https://www.bellevue.ch/all-de/all/investor-relations/corporate-news/patrik-gilli-wird-chief-financial-officer-der-bellevue-group2022-02-18T11:21:20+01:00https://www.bellevue.ch/all-de/all/investor-relations/corporate-news/bellevue-group-verkauft-bank-an-kbl-epb-strategischer-fokus-auf-das-asset-management-und-privatmarktgeschaeft2022-02-18T11:21:20+01:00https://www.bellevue.ch/all-de/all/investor-relations/corporate-news/bellevue-group-schliesst-uebernahme-von-adbodmer-ag-erfolgreich-ab-jan-kollros-neues-mitglied-der-gruppenleitung2022-02-18T11:21:20+01:00https://www.bellevue.ch/all-de/all/investor-relations/corporate-news/bellevue-group-verkauft-six-beteiligung-erloes-soll-mehrheitlich-fuer-weitere-geschaeftsentwicklung-genutzt-werden2022-02-18T11:21:20+01:00https://www.bellevue.ch/all-de/all/investor-relations/corporate-news/bellevue-group-prueft-strategische-optionen-fuer-bank-am-bellevue2022-02-18T11:21:20+01:00https://www.bellevue.ch/all-de/all/investor-relations/corporate-news/bellevue-group-erweitert-anlagekompetenzen-uebernahme-der-private-equity-boutique-adbodmer-ag2022-02-18T11:21:20+01:00https://www.bellevue.ch/all-de/all/investor-relations/corporate-news/bellevue-group-mit-voraussichtlichem-konzerngewinn-von-knapp-chf-20-mio-veit-de-maddalena-als-neuer-vr-praesident-sowie-zwei-neue-vr-mitglieder-vorgeschlagen2022-02-18T11:21:20+01:00https://www.bellevue.ch/all-de/all/investor-relations/corporate-news/aufwertung-der-beteiligung-an-der-six-group2022-02-18T11:21:20+01:00https://www.bellevue.ch/all-de/all/investor-relations/corporate-news/veraenderungen-bei-den-cfo-funktionen-der-bellevue-group2022-02-18T11:21:20+01:00https://www.bellevue.ch/all-de/all/investor-relations/corporate-news/gruppenbildung-von-aktionaeren2022-02-18T11:21:20+01:00https://www.bellevue.ch/all-de/all/investor-relations/corporate-news/veraenderungen-im-verwaltungsrat-der-bellevue-group2022-02-18T11:21:20+01:00https://www.bellevue.ch/all-de/all/investor-relations/corporate-news/bellevue-group-mit-halbjahresgewinn-von-rund-chf-11-5-mio2022-02-18T11:21:20+01:00https://www.bellevue.ch/all-de/all/investor-relations/corporate-news/bellevue-groups-tochtergesellschaft-starcapital-erwirbt-deutsche-mars-asset-management-gmbh2022-02-18T11:21:20+01:00https://www.bellevue.ch/all-de/all/investor-relations/corporate-news/bellevue-group-mit-erwartetem-operativem-ergebnis-von-rund-chf-29-mio-voraussichtlicher-konzerngewinn-nach-steuern-von-rund-chf-21-mio2022-02-18T11:21:20+01:00https://www.bellevue.ch/all-de/all/investor-relations/corporate-news/bellevue-baut-sales-aktivitaeten-im-asiatischen-raum-weiter-aus2022-02-18T11:21:20+01:00https://www.bellevue.ch/all-de/all/investor-relations/corporate-news/generalversammlung-der-bellevue-group-ag-alle-antraege-angenommen2022-02-18T11:21:20+01:00https://www.bellevue.ch/all-de/all/investor-relations/corporate-news/bellevue-group-steigert-konzerngewinn-um-59-auf-chf-22-3-mio-kundenvermoegen-mit-chf-12-mrd-auf-neuem-hoechststand2022-02-18T11:21:20+01:00https://www.bellevue.ch/all-de/all/investor-relations/corporate-news/bellevue-erweitert-produktpalette-im-private-equity-bereich2022-02-18T11:21:20+01:00https://www.bellevue.ch/all-de/all/investor-relations/corporate-news/bellevue-group-steigert-das-operative-ergebnis-um-rund-15-auf-chf-17-5-mio-healthcare-strategien-erfreuen-sich-grosser-nachfrage2022-02-18T11:21:20+01:00https://www.bellevue.ch/all-de/all/investor-relations/corporate-news/generalversammlung-der-bellevue-group-ag-alle-antraege-angenommen-12022-02-18T11:21:20+01:00https://www.bellevue.ch/all-de/all/investor-relations/corporate-news/bellevue-group-steigert-operatives-ergebnis-um-31-auf-chf-39-8-mio-gute-wachstumsbasis-durch-anstieg-der-kundenvermoegen-auf-chf-10-6-mrd2022-02-18T11:21:20+01:00https://www.bellevue.ch/all-de/all/investor-relations/corporate-news/global-macro-management-team-von-bellevue-erhaelt-verstaerkung2022-02-18T11:29:58+01:00https://www.bellevue.ch/all-de/all/investor-relations/corporate-news/bellevue-asset-management-verstaerkt-sales-team-in-der-schweiz2022-02-18T11:29:58+01:00https://www.bellevue.ch/all-de/all/investor-relations/corporate-news/bellevue-group-steigert-konzerngewinn-um-23-auf-chf-14-2-mio-strategische-weiterentwicklung-wird-fortgesetzt2022-02-18T11:29:58+01:00https://www.bellevue.ch/all-de/all/investor-relations/corporate-news/generalversammlung-der-bellevue-group-ag-alle-antraege-angenommen-22022-02-18T11:29:58+01:00https://www.bellevue.ch/all-de/all/investor-relations/corporate-news/bellevue-group-erwirtschaftet-konzerngewinn-von-chf-20-mio-verstetigung-der-ergebnisse-dank-hoher-ertragsqualitaet2022-02-18T11:29:58+01:00https://www.bellevue.ch/all-de/all/investor-relations/corporate-news/bellevue-fonds-erhaelt-oesterreichisches-nachhaltigkeitssiegel-von-frau-bundesministerin-elisabeth-koestinger2022-02-18T11:29:58+01:00https://www.bellevue.ch/all-de/all/investor-relations/corporate-news/bellevue-group-steigert-halbjahresgewinn-um-17-auf-chf-11-5-mio-kundenvermoegen-auf-rekordniveau-als-basis-fuer-weiteres-wachstum2022-02-18T11:29:58+01:00https://www.bellevue.ch/all-de/all/investor-relations/corporate-news/bellevue-groups-tochtergesellschaft-starcapital-schliesst-uebernahme-von-mars-asset-management-erfolgreich-ab2022-02-18T11:29:58+01:00https://www.bellevue.ch/all-de/all/investor-relations/corporate-news/generalversammlung-der-bellevue-group-ag-alle-antraege-angenommen-32022-02-18T11:29:58+01:00https://www.bellevue.ch/all-de/all/investor-relations/corporate-news/bellevue-group-erwirtschaftet-operativen-gewinn-von-ueber-chf-29-mio-kundenvermoegen-mit-chf-12-mrd-auf-hoechststand2022-02-18T11:29:58+01:00https://www.bellevue.ch/all-de/all/investor-relations/corporate-news/die-bellevue-group-ag-wird-zum-2-mal-mit-dem-swiss-climate-label-co2-neutral-ausgezeichnet2022-12-16T13:07:28+01:00https://www.bellevue.ch/all-de/all/investor-relations/corporate-news/die-bellevue-group-ag-wird-mit-dem-qualitaetsguetesiegel-des-swiss-arbeitgeber-awards-ausgezeichnet2022-12-16T13:07:43+01:00https://www.bellevue.ch/all-de/all/investor-relations/corporate-news/bellevue-baut-private-markets-bereich-weiter-aus2022-12-19T07:05:18+01:00https://www.bellevue.ch/all-de/all/investor-relations/corporate-news/bellevue-asset-management-lanciert-private-equity-secondaries-fonds2023-01-16T15:31:13+01:00https://www.bellevue.ch/all-de/all/investor-relations/corporate-news/bellevue-erwartet-deutlich-tieferen-konzerngewinn-von-chf-25-mio-antrag-einer-ordentlichen-dividende-von-chf-2-002023-01-25T20:25:43+01:00https://www.bellevue.ch/all-de/all/investor-relations/corporate-news/bellevue-staerkt-team-in-frankfurt-mit-christopher-hoenig-und-stefan-koehling2023-02-02T08:48:18+01:00https://www.bellevue.ch/all-de/all/investor-relations/corporate-news/veraenderungen-im-verwaltungsrat-der-bellevue-group-12023-02-21T18:00:57+01:00https://www.bellevue.ch/all-de/all/investor-relations/corporate-news/bellevue-mit-marktbedingt-reduziertem-konzerngewinn-von-chf-25-3-mio-beantragte-dividende-unterstreicht-solides-geschaeftsmodell-und-zuversicht2023-02-27T14:50:21+01:00https://www.bellevue.ch/all-de/all/investor-relations/corporate-news/generalversammlung-der-bellevue-group-ag-alle-antraege-angenommen-52023-03-21T18:41:39+01:00https://www.bellevue.ch/all-de/all/investor-relations/corporate-news/bellevue-erwartet-im-vorjahresvergleich-deutlich-tieferes-halbjahresresultat-12023-06-20T18:00:45+02:00https://www.bellevue.ch/all-de/all/investor-relations/corporate-news/bellevue-mit-marktbedingt-tieferem-konzerngewinn-von-chf-8-mio-weiterer-ausbau-von-privatmarktanlagen-als-kuenftige-ertragsquelle2023-07-27T07:00:49+02:00https://www.bellevue.ch/all-de/all/investor-relations/corporate-news/gebhard-giselbrecht-wird-neuer-ceo-der-bellevue-group2023-08-27T18:04:04+02:00https://www.bellevue.ch/all-de/all/investor-relations/corporate-news/bellevue-asset-management-baut-vertriebsteam-in-deutschland-weiter-aus2023-09-06T10:29:57+02:00https://www.bellevue.ch/all-de/all/investor-relations/corporate-news/bellevue-asset-management-lanciert-obesity-solutions-fonds2023-11-14T15:26:43+01:00https://www.bellevue.ch/all-de/all/investor-relations/corporate-news/veraenderungen-in-der-geschaeftsleitung-der-bellevue-group2023-11-23T08:05:47+01:00https://www.bellevue.ch/all-de/all/investor-relations/corporate-news/investieren-in-die-zukunft-der-gesundheitsbranche-bellevue-lanciert-innovativen-ai-health-fonds2024-01-12T14:34:47+01:00https://www.bellevue.ch/all-de/all/investor-relations/corporate-news/bellevue-erwartet-deutlich-tieferen-konzerngewinn-von-chf-15-mio-antrag-einer-ordentlichen-dividende-von-chf-1-152024-01-29T19:00:27+01:00https://www.bellevue.ch/all-de/all/investor-relations/corporate-news/bellevue-group-mit-marktbedingtem-rueckgang-des-konzernergebnisses-auf-chf-15-2-mio-dividende-von-chf-1-15-beantragt-vielversprechende-erholung-der-schluesselmaerkte-seit-q4-20232024-02-27T07:03:59+01:00https://www.bellevue.ch/all-de/all/investor-relations/corporate-news/generalversammlung-der-bellevue-group-ag-alle-antraege-angenommen-20242024-03-20T18:00:03+01:00https://www.bellevue.ch/all-de/all/investor-relations/corporate-news/bellevue-group-mit-konzerngewinn-von-chf-7-4-mio-stabilisierung-der-verwalteten-kundenvermoegen-dank-verhaltenem-marktaufschwung2024-07-25T07:00:39+02:00https://www.bellevue.ch/all-de/all/investor-relations/corporate-news/bellevue-erweitert-salesteam-im-markt-schweiz2024-09-09T13:51:52+02:00https://www.bellevue.ch/all-de/all/investor-relations/corporate-news/15-jahre-bellevue-medtech-services-fonds-eine-erfolgsgeschichte-bei-gesundheitsinvestments2024-10-03T14:30:34+02:00https://www.bellevue.ch/all-de/all/investor-relations/corporate-news/rueckkehr-an-ursprungsstandort-bellevue-group-zieht-an-theaterstrasse-12-sechselaeutenplatz-am-bellevue2025-01-09T11:35:42+01:00https://www.bellevue.ch/all-de/all/investor-relations/corporate-news/bellevue-erwartet-im-vorjahresvergleich-deutlich-tieferes-konzernergebnis2024-12-02T19:31:39+01:00https://www.bellevue.ch/all-de/all/investor-relations/corporate-news/bellevue-group-verstaerkt-aktivitaeten-in-asien-mit-eigener-niederlassung-in-singapur2025-01-08T14:27:15+01:00https://www.bellevue.ch/all-de/all/investor-relations/corporate-news/bellevue-group-erzielt-konzerngewinn-von-chf-9-2-mio-marktbedingte-reallokation-von-kundengeldern2025-02-24T17:30:22+01:00https://www.bellevue.ch/all-de/all/investor-relations/corporate-news/generalversammlung-der-bellevue-group-ag-alle-antraege-angenommen-20252025-03-18T17:55:30+01:00https://www.bellevue.ch/all-de/all/investor-relations/corporate-news/fuehrungswechsel-bei-der-bellevue-group-sukzessive-schaerfung-des-geschaeftsmodells-halbjahresresultat-voraussichtlich-deutlich-tiefer-als-vorjahr2025-06-02T11:47:39+02:00https://www.bellevue.ch/all-de/all/investor-relations/corporate-news/bellevue-group-mit-ausgeglichenem-resultat-von-chf-0-2-mio-healthcare-sektor-mit-aussichtsreichem-potenzial-weitere-performanceverbesserungen2025-09-30T17:34:47+02:00https://www.bellevue.ch/all-de/all/investor-relations/corporate-news/bellevue-verstaerkt-vertriebsteam-in-deutschland2025-10-02T08:36:46+02:00https://www.bellevue.ch/all-de/all/investor-relations/corporate-news/bellevue-lanciert-ersten-aktiv-verwalteten-etf-fokus-liegt-auf-gesundheitsaktien2025-09-30T17:32:39+02:00https://www.bellevue.ch/all-de/all/investor-relations/corporate-news/diya-lowe-uebernimmt-als-head-of-distribution-asia-pacific2025-10-02T08:38:51+02:00https://www.bellevue.ch/all-de/all/investor-relations/corporate-news/bellevue-group-verkauft-adbodmer-ag-im-rahmen-eines-management-buy-outs-weitere-schaerfung-des-geschaeftsmodells2025-10-09T17:44:52+02:00https://www.bellevue.ch/all-de/all/investor-relations/corporate-news/neuer-investment-manager-fuer-bellevue-healthcare-trust-redimensionierung-der-uk-aktivitaeten2025-10-30T08:06:30+01:00https://www.bellevue.ch/all-de/all/investor-relations/corporate-news/bellevue-asset-management-verstaerkt-healthcare-research-mit-zwei-erfahrenen-analysten2025-11-25T14:46:46+01:00https://www.bellevue.ch/all-de/all/investor-relations/corporate-news/bellevue-group-erzielt-konzerngewinn-von-chf-1-9-mio-fuer-2025-kostenreduktion-von-16-dank-effizienzmassnahmen-und-fokussierung-des-geschaeftsmodells-auf-bewaehrte-staerken2026-02-23T14:35:28+01:00https://www.bellevue.ch/all-de/all/investor-relations/corporate-news/generalversammlung-der-bellevue-group-ag-alle-antraege-angenommen-62026-03-24T17:50:21+01:00https://www.bellevue.ch/all-de/all/investor-relations/corporate-news/investor-relations2024-12-02T18:12:14+01:00https://www.bellevue.ch/all-de/all/rechtliche-hinweise2021-07-23T08:44:12+02:00https://www.bellevue.ch/all-de/all/rechtliche-hinweise/podcast2023-03-31T13:58:55+02:00https://www.bellevue.ch/all-de/all/datenschutz2021-07-23T11:49:26+02:00https://www.bellevue.ch/all-de/all/impressum2021-07-23T10:26:57+02:00https://www.bellevue.ch/all-de/all/nutzungsbedingungen2021-07-23T11:49:34+02:00https://www.bellevue.ch/all-de/all/anteilsklassen2021-09-09T20:16:54+02:00https://www.bellevue.ch/all-de/all/glossar2021-11-04T15:34:07+01:00https://www.bellevue.ch/all-de/all/event-anmeldeformular2024-11-27T16:12:53+01:00https://www.bellevue.ch/all-de/all/anmeldung-erfolgreich2024-11-27T08:36:50+01:00https://www.bellevue.ch/all-de/all/praesentationen-events2024-11-27T10:08:06+01:00https://www.bellevue.ch/all-de/all/anmeldung-bellevue-newsletter2023-09-13T14:58:23+02:00https://www.bellevue.ch/all-de/all/bellevue-uk-newsletter2023-09-13T14:58:23+02:00https://www.bellevue.ch/all-de/all/healthcare-paper2024-06-18T09:54:41+02:00https://www.bellevue.ch/all-de/all/contacts/sandro-tiziani2022-05-19T11:06:30+02:00https://www.bellevue.ch/all-de/all/contacts/heiko-ulmer2022-05-19T10:25:14+02:00https://www.bellevue.ch/all-de/all/contacts/heiko-ulmer-12024-06-24T13:05:52+02:00https://www.bellevue.ch/all-de/all/contacts/jean-pierre-gerber2022-05-19T10:31:40+02:00https://www.bellevue.ch/all-de/all/contacts/florin-boetschi2022-05-19T10:46:09+02:00https://www.bellevue.ch/all-de/all/15-jahre-bellevue-medtech2024-09-23T17:40:08+02:00https://www.bellevue.ch/all-de/all/bellevue-ai-health2024-01-16T09:27:53+01:00https://www.bellevue.ch/all-de/all/in-die-gesundheitsindustrie-von-morgen-investieren2024-03-15T10:48:42+01:00https://www.bellevue.ch/all-de/all/bellevue-healthcare-etf2025-09-17T15:45:24+02:00